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ABSTRACT 
 
 Porcine reproductive and respiratory syndrome virus (PRRSV) is a rapidly mutating 
pathogen eliciting respiratory and reproductive disease of high economic consequence. The 
PRRSV non-structural protein 2 (nsp2) is a large multifunctional protein encoded by the 
most genetically diverse region of the genome – the selective pressure potentiating mutation 
within this region is unknown. Here we report the identification of a unique function of nsp2 
as a structural component of the PRRSV virion; the first PRRSV structural protein identified 
which is not expressed from a sub-genomic RNA or regulated via the discontinuous 
transcription pathway. Through the use of a set of custom α-nsp2 antibodies nsp2 was 
identified on the surface of the PRRSV virion by immunoelectron microscopy. Further, a 
class of nsp2 isoforms was defined to be packaged within or upon the PRRSV virion. Nsp2 
packaging was found to be conserved across a panel of highly divergent stains of PRRSV 
including the genotype 1 and genotype 2 prototype strains as well as contemporary and 
highly-pathogenic isolates. 
 Next the hydrophobic domain of nsp2 was characterized as a putative multi-pass 
transmembrane domain predicted to facilitate nsp2 packaging through association with the 
viral envelope. Within an in vitro cell-free translation system nsp2 was found to strongly 
associate with canine microsomal membranes. Through high-speed ultracentrifugation, 
protease protection assay, and immunoprecipitation nsp2 was defined as an integral 
membrane protein and additionally identified to display an unexpected N-terminal 
cytoplasmic / C-terminal luminal topological orientation. Finally, membrane isolation 
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demonstrated two sub-dominant nsp2 isoforms of approximately 117 and 106 kDa in size 
and of unknown composition or function were enriched within membranes.  
 Together, these results define previously unknown attributes of nsp2. Identification of 
nsp2 as a structural protein implicates it in previously unpredicted functions related to 
attachment, entry, or early replication events and further provides rationale for the high 
mutation rate and robust adaptive immune response targeting the nsp2 protein. 
Characterization of the nsp2 transmembrane domain demonstrates its role as an integral 
membrane protein and additionally raises new questions related to the unexpected 
topological orientation or enrichment of select isoforms within the membrane fraction. 
.
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CHAPTER 1. GENERAL INTRODUCTION 
 
 
INTRODUCTION 
Positive strand RNA viruses make up the largest group of viral agents, possess high 
evolutionary potential, and infect a wide range of hosts including animals, plants, insects, and 
bacteria (1, 2). The replicating enzyme of RNA viruses, the RNA dependent RNA 
polymerase (RdRp), is highly error prone within positive-sense RNA viruses (10
-6
 to 10
-3 
[avg. mutation rate]/base pair) (3). Evolution within the context of high mutation frequencies 
has resulted in a robust phenotype to genetic change for many viruses and thus enables 
positive-sense RNA viruses to respond quickly to selective pressure(s) (4-9). Upon infection, 
the messenger RNA (mRNA) genome serves as template for the initial round of translation –
allowing rapid viral gene expression without the immediate requirement for transcription. 
The rapid growth kinetics and high mutation frequency of positive-sense RNA viruses 
complicates eradication efforts and limits efficacy of conventional control strategies.  
Porcine reproductive and respiratory syndrome virus (PRRSV) is an enveloped, 
single-stranded positive-sense RNA virus within the Arteriviridae family. PRRSV infection 
induces immunodysregulation in the infected host by preferentially targeting the macrophage 
and through a range of immunomodulatory mechanisms (10-13). PRRSV has maintained a 
worldwide epidemic since its emergence in the late 1980’s through a continual set of 
emerging and re-emerging strains of high genetic and antigenic heterogeneity (14-19). Due to 
an extraordinary evolution rate, efficient transmission, and high infectability of PRRSV, 
current control and eradication efforts including vaccination strategies seem unlikely to be 
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broadly efficacious. Investigation of basic PRRSV biology and immunology is needed to 
define molecular targets with therapeutic potential. 
The PRRSV genome encodes at least 14 nonstructural proteins (nsp) and eight 
structural proteins through two distinct transcription/translation regulatory mechanisms (20, 
21). The first three-fourths of the genome exclusively encode nsps (nsp1α/β, nsp2-6, 
nsp7α/β, nsp 8-12) from the positive-sense mRNA genome. The final one-fourth of the 
genome encodes all canonical structural proteins that together make up the virion (GP2a/b, 
GP3-4, GP5 and 5a, M, N). These structural proteins are generated through a negative strand 
intermediate via a complex co-terminal discontinuous transcription strategy (21, 22). Of the 
PRRSV proteome, little is known about nsp functionality outside of the four characterized 
viral proteases (papain-like cysteine protease 1α (PLP1α), PLP1β, PLP2, main serine 
protease (SP)), the replicase, and the helicase enzymatic functions (23-25). Since viral 
genomes utilize highly efficient coding strategies, and additionally, viruses like PRRSV are 
further constrained in genome size due to their RdRp error rate (26), large proteins of 
unknown function are of particular interest. The PRRSV nsp2 is both the largest and the most 
genetically diverse protein encoded within the PRRSV genome. Nsp2 contains an N-terminal 
papain-like cysteine protease (PLP2), which also possesses deubiquitinating functionality, a 
central bipartite hypervariable region (HV), a predicted multi-transmembrane spanning 
element (TM) and a generally well-conserved C-terminal region of unknown function. The 
ultimate size of nsp2 coupled with the significant elevation of mutation frequency within this 
coding region suggests nsp2 functions in additional unknown mechanisms critical for 
PRRSV entry, replication, or immune evasion.  
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In the following chapters evidence is presented to detail unexpected functions for 
nsp2 as a novel structural component of the PRRSV virion, to biochemically determine the 
nature of the putative nsp2 transmembrane elements, and to investigate the mechanism(s) by 
which recently described nsp2 isoforms are generated. 
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CHAPTER 2. LITERATURE REVIEW 
 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the etiological agent 
of a world-wide epidemic termed porcine reproductive and respiratory syndrome (PRRS). 
PRRSV is highly host and tissue restricted to swine cells of the monocyte lineage, 
preferentially infecting the porcine alveolar macrophage (AMΦ) (1). PRRSV first emerged in 
the late 1980s as a ‘mystery’ disease progressing through swine populations in both Europe 
and North America (2-6). Prevailing clinical symptoms were noted to be respiratory distress 
in young hosts and widespread reproductive failure in pregnant sows including mummified, 
stillborn and aborted fetuses (7). Initial characterization of circulating European (EU, Type 1) 
and North American (NA, Type 2) genotype isolates were found to be surprisingly 
genetically divergent. Although overall disease phenotype, gross clinical symptoms, genomic 
organization and temporal emergence were all similar, these strains differed by ~40% at the 
nucleotide level (3, 5, 8). The degree of genetic heterogeneity suggests a protracted period of 
independent evolution on the two continents (9); molecular clock analysis predicts the 
divergence of the two genotypes from a common ancestor between a decade to over a 
century prior to clinical recognition (10, 11), presumably from another host species (12). The 
origin of PRRSV remains unknown and no secondary animal, human, or arthropod vectors 
have been identified to date (13-17). In the ~25 years since the first emergence of PRRSV, a 
global epidemic has been sustained by a set of emerging and re-emerging strains supported 
by high frequency mutation and recombination (18-20). PRRSV remains the most 
economically devastating disease of swine and contributes to the deterioration of animal 
health through disease and the continual emergence of increasingly virulent strains (21-24).  
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GENOME AND REPLICATION 
PRRSV is a member of the Arteriviridae family within the order Nidovirales. The 
Nidovirus order constitutes a group of positive-sense RNA viruses which share a hallmark 
replication/transcription strategy, similar genomic organization, and a defining set of genetic 
elements (25). Despite the strong genetic similarities between the nidoviruses, they differ 
biologically in many ways including host species and range, disease phenotype, virion 
morphology, cellular tropism, genomic size and encoded content (26). The similar genomic 
organization, characteristic genetic elements and common functionality of orthologous 
proteins has however led to the acceptance of many putative functions for PRRSV proteins; 
often derived from studies of the arterivirus prototype species equine arteritis virus (EAV) 
and the more distantly related coronaviruses. Classically the nidoviral families could be 
categorized into large nidoviruses (Coronaviridae, Roniviridae; ~28-32Kbs) and ‘small’ 
nidoviruses (Arteriviridae; ~15Kbs) based on genome size; however the recently described 
Mesoniviridae of intermediate length (mesos = medium; ~20Kbs) depicts the large genomic 
size range the Nidovirus order inhabits (26, 27). The Arteriviridae is composed of four viral 
species which share similar genetic and biological characteristics such as genomic 
organization and content, and a cellular tropism for the macrophage lineage (28). Viral 
species include PRRSV, simian hemorrhagic fever virus (SHFV), lactate-dehydrogenase 
elevating virus (LDV) and the equine arteritis virus (EAV; arterivirus prototype species) (25, 
29).  
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Genome Organization 
 The PRRSV genome is approximately 15Kb in length and expresses a range of 
accessory and structural proteins through two distinct transcription mechanisms. The 
genomic organization and associated expression profiles are depicted in Figure 2.1. The 
PRRSV genome encodes a 5’ proximal non-coding element (untranslated region; UTR) of 
approximately 217-222 nucleotides (nt) (EU) and 188-191nt (NA) in length (data not 
shown). The 5’UTR performs functions important for transcriptional priming, translation 
initiation, and the coalescing junctional site for all sub-genomic RNA products (sgRNA; 
discussed below) (30-35).  
Directly downstream of the 5’UTR are the large overlapping replicase open reading 
frames (ORF). The ORF1a/b share a single translational start site but is augmented by two 
ribosomal frameshift (RFS) sites at genomic positions 3,889nt (RFS1; nsp2) and 7,695nt 
(RFS2; nsp8/9) [VR-2332 (U87392) reference sequence] (36, 37). The RFS1 site within nsp2 
has only recently been identified and the terminology associating the newly defined ORF and 
polyprotein is forthcoming. Two products are generated from the RFS1 site; a -1 RFS occurs 
approximately 7% of the time and results in an immediate termination of translation (nsp2N) 
(38). Additionally, a -2 RFS event occurs at ~20% efficiency and yields a translational 
extinction in the -2 coding frame through the putative transmembrane domain of nsp2 to 
generate the product nsp2TF (36). In order to maintain a consistent nomenclature the RFS1 
polyprotein products will be referred to herein as pp1a-nsp2N (-1 RFS) and pp1a-nsp2TF (-2 
RFS), or collectively as pp1a-nsp2.  
Unlike the canonical structural proteins, the large replicase polyproteins pp1a-nsp2, 
pp1a, and pp1ab are generated from the mRNA PRRSV genome. Using the North American  
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Figure 2.1. PRRSV genome, transcription, and translation. PRRSV replication proceeds by a range of 
genetic and protein regulatory mechanisms. Expression of the first three-fourths of the ~15Kb genome yields 
multiple polyproteins (ORF1a-nsp2, ORF1a, ORF1b) through two documented programmed RFS. Polyproteins 
are co-translationally and post-translationally processed into at least 14 distinct replicase (accessory) 
nonstructural proteins (nsps) by four virally encoded proteases PLP1α, PLP1β, PLP2, and SP. Canonical 
structural proteins are expressed exclusively through a set of sub-genomic RNAs (sgRNA’s; RNA2-7) via a co-
terminal discontinuous transcription strategy via a negative-sense strand intermediate (see below).  
 
(Type 2) prototype strain VR-2332 (U87392) for a reference, ORF1a/b is encoded by a 5’ 
proximal segment of approximately 12 Kb [7512nt ORF1a, 4374nt ORF1b] yielding four 
distinct polyproteins including pp1a-nsp2N (1,234 amino acids (aa); -1 RFS at RFS1), pp1a-
nsp2TF (1,403aa; -2 RFS at RFS1), pp1a (2,503aa), and pp1ab (3,960aa; -1 RFS at RFS2) 
(Figure 2.1).   
The replicase polyproteins are co-translationally and post-translationally processed 
into at least 14 distinct nonstructural proteins (nsp) via four virally encoded proteinases 
including papain-like cysteine proteinase 1α (PLP1α; nsp1α), PLP1β (nsp1β), PLP2 (nsp2), 
and the main serine proteinase (SP; nsp4) (25). PLP1α and PLPβ function to cleave the 
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nsp1α↓nsp1β and the nsp1β↓nsp2 junction, respectively; PLP2 is responsible for the cleavage 
of the nsp2
↓
nsp3 junction and the main SP processes all remaining nsp products (nsp3-12) 
(39). pp1a-nsp2 is the smallest of the polyprotein precursors, composed of nsp1α, nsp1β, and 
a truncated form of nsp2. ORF1a encodes the pp1a encompassing nsps 1-8, and the ORF1ab 
encodes the pp1ab composed of all known nsps (nsp1α/β, nsp2-6, nsp7α/β, nsp8-12) whereas 
nsp9 is a translational extension of nsp8 via a programed -1 RFS at position 7,695nt (RFS2) 
(Figure 2.1) (37). In contrast, structural proteins are encoded and individually expressed by a 
set of sgRNA’s through a negative-strand intermediate (RNA2-7; Figure 2.1) (40). sgRNA’s 
are genetically polycistronic (except RNA7) but are functionally monocistronic/bicistronic, 
whereas only the 5’ terminal ORF(s) is expressed (Figure 2.1; colored boxes of RNA2-7 
denote the proteins derived from each RNA species). Generation of sgRNA’s and the 
resulting expression of the PRRSV structural proteins are described in detail below. Briefly, 
RNA 2 encodes ORF2a/b which is translated to yield glycoprotein 2 (GP2(a)) and a small 
non-glycosylated envelope protein (E)(GP2b); ORF3 is expressed from RNA3 to yield GP3; 
RNA4 encodes ORF4 yielding GP4 – together GP2, GP3, and GP4 form a trimeric complex 
resulting in the ‘minor’ glycoprotein complex which functions in viral entry (41). RNA5 
encodes ORF5 and 5a, ORF5 is translated into GP5 whereas ORF5a encodes a small protein 
only recently described (42, 43) and of unknown function. ORF6 is expressed from RNA6 
resulting in the generation of the membrane protein (M), GP5 and M form a disulfide linked 
dimer and together constitute the ‘major’ glycoprotein complex on the PRRSV virion (44). 
Finally, the nucleocapsid protein (N) is encoded by ORF7 and expressed from RNA7. N is 
the major structural element within the PRRSV virion, functions to package the viral 
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genomic RNA (gRNA), and is the only known structural protein which does not encode a 
transmembrane domain or to not have an ectodomain upon the PRRSV virion (45-51).  
 
5’ and 3’ UTR 
Flanking the core protein coding regions of the PRRSV genome are the 5’ and 3’ 
UTRs. Both the 5’ and 3’ UTR are implicated as essential components contributing to the 
viral strategies imparting replicative and translational functionality; however, the exact 
functions of the 5’ and 3’ UTRs, and the associated mechanisms of interaction, are poorly 
understood. The 5’UTR is encoded within the first ~220nt (EU) or ~189nt (NA) within the 
PRRSV genome and is believed to possess a putative type I 5’ Cap structure (Figure 2.1; 
(52)). The 3’ UTR is located directly downstream of ORF7 (Figure 2.1) and is encoded by 
approximately 150nt excluding the polyadenylation site. Polyadenylation of the 3’ termini is 
essential to viral viability (35). Both the 5’ UTR and the 3’ UTR encode conserved putative 
RNA secondary structures important to replicative function. The maintenance of this higher 
order structure(s) may supersede requirements for conservation of a primary sequence within 
these regions (32-34, 53).  
The 5’UTR is genetically variable between strains whereas EU and NA strains share 
approximately 55% genetic homology within the 5’ UTR (31, 54). While genetic 
heterogeneity is noted within the 5’UTR, mutations within this region are often deleterious 
(35). Viable mutations appear to maintain a conserved RNA secondary structure defined by 
stem-loop structures (SL) extending from a central bulge (Figure 2.2) (54). The RNA 
secondary structure is considered critical to the function of the 5’UTR (31), particularly in 
regards to the generation of sgRNA’s (40). The 5’UTR is initiated by an AU-rich region with 
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a highly conserved AUG as the first three nucleotides. This AUG codon appears to be 
nonfunctional, as no protein product has been defined from this region, and is nonessential to 
PRRSV replication (35). While a small fraction of the AU-rich region can be deleted without 
lethality to the virus (~5% of the UTR), passage 0 (P0) shows significantly diminished 
growth of these deletion mutants and all recovered progeny displayed 5’ ends repaired with 
AU rich sequence from an unknown source (33); demonstrating a rapid restoration of this 
region to retain viability. Analysis of the RNA structure of the 5’UTR of three North 
American reference strains, nine North American field strains, and two European strains 
noted that field isolates had an internal bulge within the stem-loop of a variable structural 
domain 4 (SL4) (Figure 2.2), while cell culture adapted strains all lacked this element (54). 
Cell culture adaptation of a field isolate strain resulted in loss of the base-pair mismatch 
‘bulge’ (54). The importance or functionality of the noted genetic heterogeneity within and 
around SL4 (Figure 2.2A), including the central bulge on SL4, is unknown. Cellular factors 
including the poly-C binding proteins (PCBP) 1 and 2 have been reported to interact with the 
5’ UTR (55). siRNA knock-down of PCBP1 and PCBP2 resulted in attenuation of PRRSV 
RNA genomic and anti-genomic replication, but not translation of the replicase proteins from 
the mRNA genome (55). Detailed studies of the distantly related coronavirus species have 
shown the 5’UTR of nidoviruses are regulators of genomic replication, transcription, and 
mRNA translation and are considered a necessary docking site for a variety of viral and host 
factors to complete these functions (56-58).  
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Figure 2.2. Predicted RNA secondary structure of the NA PRRSV 5’UTR. The PRRSV 5’UTR maintains a 
conserved RNA secondary structure which is critical to sgRNA synthesis, including cis-acting elements within 
the SL domains. A) (ΔG) free energy dot plot (VR-2332 5’UTR 1-189nt; MFold prediction algorithm (59)), 
upper triangle shows possible stable structures: red = lowest free energy (most stable), black = highest free 
energy (least stable); lower triangle (below slopped line): optimal energy structures. Each plot point is the 
predicted base-paring interaction between i base (x-axis) and j base (y-axis) so that plot point (2,45) is the base-
pair interaction of the second nucleotide with the 45
th
 base (1
st
 base-pair interaction in SL1). B) Graphical 
representation of putative RNA secondary structure (RNAFold) of the VR-2332 5’UTR showing the conserved 
SL1-5 radiating from a central bulge structure. RNAfold prediction algorithm accessed from the Geneious 
parental program (v6.1.6). 
 
Current data suggests the polyadenylated 3’UTR is the initiating factor for synthesis 
of negative-sense gRNA and sgRNA transcription through one or more cis-acting elements, 
possibly including long-range RNA-RNA interactions, and acts through both primary RNA 
sequence and conserved secondary structure motifs (35, 60, 61). Through genetic probing of 
the N gene two highly conserved SL structures, one within the ORF7 coding region and one 
within the 3’UTR, were identified. The kissing loop interaction between these two SL 
structures was found to be critical for viral replication (53). Mutation of the predicted loop-
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loop interaction domain abolished replication whereas secondary mutation restoring potential 
complimentary base pairing also restored replication (53). While it has been shown that some 
regions of the 3’UTR are dispensable without loss of viral growth kinetics (62), even small 
changes (single-nucleotide mutation) within the 3’UTR can have a range of deleterious 
effects (60). For instance, mutational probing of the 3’UTR identified a critical primary 
sequence within the tetranucleotide sequence at the 3’ termini, directly upstream to the poly-
A region (5’-AAUUAAA…An-3’) (60). Interestingly, mutation of each nucleotide resulted in 
slightly different phenotypic outcomes. Replacement of the final uracil base at the 3’ termini 
was fatal with a purine (adenine or guanine) substitution, but cytosine substitution had no 
effect on viral viability. Alteration of the upstream uracil base significantly reduced the 
synthesis of sgRNA and viral growth for all substitutions. Replacement of the 3’ proximal 
adenine (AAUU) did not appear to effect sgRNA synthesis or N protein expression, but 
resulted in a nonviable phenotype for unknown reasons. Finally, an alteration of the 5’ 
proximal adenine showed reduced (-) gRNA synthesis when replaced with a guanine base. 
These data show that the coding strategies for the 5’ UTR and the 3’ UTR are complex. 
Whereas some regions are robust to mutation, many domains maintain a requirement for 
stable secondary structures or primary sequence critical for specific replicative function 
including gRNA synthesis, sgRNA transcription, or possibly non-transcription related 
functions.  
 
REPLICATION 
Due to the unique attributes of Nidovirus transcription and replication including 
uncharacteristically large polycistronic RNA genomes and the transcription of a nested set of 
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5’, 3’ co-terminal sgRNA’s through a discontinuous transcription strategy, nidovirus RNA 
synthesis mechanisms have been suggested to be of unparalleled complexity among positive 
strand RNA viruses (26, 63). PRRSV replication closely ties three key features: 
rearrangement of host membranes to establish viral replication complexes (RC), synthesis 
and expression of gRNA, and transcription of sgRNA for the efficient expression of 
structural proteins. Genesis of gRNA (replication) and sgRNA are inherently tied through the 
shared negative strand synthesis mechanism. Modulation of negative-sense transcription 
through a non-stochastic mechanism yields either gRNA or one of six sgRNA’s (RNA2-7) 
through an abortive disjoining/rejoining discontinuous transcription strategy (40, 64, 65).  
 
Membrane Rearrangement 
Little is known about the establishment of PRRSV infection, from the point of entry 
to the development of RC’s, including the formation of characteristic perinuclear double-
membrane vesicles (DMV) (66). DMVs are believed to be derived from the endoplasmic 
reticulum (ER) which are apparent sites of viral replication (67). It has been shown that the 
arterivirus replicase proteins (ORF1a/b) are sufficient to support viral replication (68). 
Through the use of point mutations abolishing the start codon selectively, through deletion of 
internal coding sequence, or through introduction of novel framshifts within each EAV 
structural protein ORFs, it was shown that replication and transcription was maintained for 
each structural protein knock-out mutant, but infectivity was lost in all cases (68). Further, 
deletion of the complete coding sequence of ORF2-6 as well as the 5’ 40nt of ORF7 resulted 
in accumulation of genomic RNA to wild-type (wt) levels, indicating the replicase proteins 
are sufficient for genomic replication (68). Additional deletion of 227nt of ORF7 [EAV 
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12350-12557] nearly eliminated genome replication (68). The authors proposed that loss of 
gRNA replication via ORF7 deletion mutants were due to disruption of a cis-acting 
replication element; supported by the later definition of the PRRSV (53) and the EAV (61) 3’ 
kissing-loop interaction between ORF7 and the 3’ UTR.  
Upon entry, the gRNA serves as the mRNA for immediate translation of the large 
replicase polyproteins. Within ORF1a, three proteins are recognized putative transmembrane 
proteins (nsp2, nsp3, and nsp5) (see chapter 4). The EAV nsp2 and nsp3 were shown to be 
sufficient to modulate host cellular membranes into structures similar to those observed 
during viral infection (69). It is believed that membrane integration and possibly protein-
protein interactions of these transmembrane proteins function to torque the existing 
membrane structures to form the DMVs; tethering the genesis and processing of the 
polyprotein(s) at the site of replication. Additional viral or cellular interacting partners are 
not well defined. The mechanism of DMV formation is a working unknown but may include 
the modulation of autophagy and/or apoptosis pathways (70-80). 
 
RdRp  
The core replicative machinery of PRRSV, the RdRp (nsp9) and the RNA helicase 
(nsp10), is encoded within ORF1b. The calculated RFS efficiency of the RFS1 (6-7% -1 
RFS; 16-20% -2 RFS) (36) and the RFS2 (~20%) (81) demonstrates that ORF1b (nsp9-12) is 
generated approximately once out of out of every six translational events (15%), suggesting 
the stoichiometric requirements for the core replicative machinery is low compared to the 5’ 
encoded replicase proteins.  
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RdRps form a characteristic right hand configuration (thumb, palm, finger(s)) with 
the thumb and fingers in contact to create a pocket for substrates (82). Comparison of single- 
and double-stranded RNA virus RdRp show structural similarity even though there is low 
sequence homology between classes (82). All polymerases share a core set of conserved 
motifs, suggesting a common ancestor, whereas the most conserved motifs are denoted A, B, 
C, and D (83). The structure of the RdRp possesses an additional conserved motif E (84). 
The RdRp of Nidoviruses are phylogenetically clustered with the picorna-like virus 
superfamily (26, 85) but possess a SDD (Ser-Asp- Asp) signature within motif C, located 
within the active site on the palm side of the RdRp. The nidoviral SDD motif is a hallmark of 
the viral family that discriminates it from all other (+) sense RNA virus groups that contain a 
GDD (Gly-Asp- Asp) motif (81). The SDD motif at this position was shown to be critical for 
EAV replication (86); surprisingly a S→G mutation within the PRRSV RdRp was replication 
competent (gRNA) but displayed deficiencies in sgRNA synthesis (87).  
Nsp10 encodes the PRRSV helicase protein (88). The PRRSV multi-domain helicase 
(HEL) is composed of the core 1A and 2A canonical domains found in super-family 1 type 
helicases, a flexible accessory domain (1B), and a unique zinc-binding domain (ZBD) (89). 
The PRRSV HEL functions to unwind dsRNA in a 5’ to 3’ polarity (88). Both the flexible 
accessory domain and the ZBD are critical to replicative function of EAV including 
generation of gRNA and sgRNA (90, 91). The helicase is predicted to function in concert 
with the RdRp to facilitate replication and transcription, however, it is not understood how 
the 5’ to 3’ directionality of the helicase and the 3’ to 5’ RdRp synthesis coordinates these 
activities (39).  
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It is unknown how the PRRSV RdRp initiates replication, either by a primer 
dependent mechanism or by de novo synthesis. To assess the activity of the EAV RdRp, a 
recombinant version of the polymerase was generated and assessed. EAV RdRp activity was 
found in the absence of a primer with poly(U) or poly(C) templates but not with poly(A) 
templates, indicating a de novo initiation method in a template specific manner (92). 
Introduction of primers to either the poly(U) or poly(C) templates reduced RdRp activity 
(92). Incubation with non-complementary bases (i.e. for Poly(U) template = GTP and UTP) 
did not result in radiolabeling, which shows the RdRp did not function as a terminal 
transferase, and radioactively labeled primers were not incorporated into the synthetic non-
viral templates (92). De novo polymerase activity could not be detected on viral templates 
however. This finding suggests the arterivirus RdRp is catalytically active without other viral 
factors and capable of de novo synthesis but may require other viral or cellular co-factors to 
efficiently perform replication or transcription processes.  
It is generally believed that (+) sense RNA viruses use conformational switches in 
their terminal non-codling regions in the form of higher order RNA secondary structure to 
regulate translation, transcription (of sgRNA’s) and genomic replication (61). To define the 
minimal cis-acting 3’ genomic element required for efficient PRRSV replication, progressive 
3’ deletions were introduced into self-limiting PRRSV replicons encoding an internal 
ribosome entry site (IRES)-driven luciferase (LUC) reporter within the deleted region (35). 
Only the smallest deletion, encoding the full M and N proteins replicated to similar levels as 
the positive control. The next smallest deletion, removing the M protein coding region but 
maintaining the complete N ORF resulted in significant loss of genome replication (35). 
Taken together with the data of the 5’UTR, 3’UTR and ORF7, these data show that key 
19 
 
genetic elements or protein interacting partners required for efficient PRRSV replication are 
interspersed within multiple coding regions of the genome.  
 
sgRNA Synthesis 
Viruses require the ability to selectively regulate transcription and translation 
processes both temporally and quantitatively in a highly ordered and balanced process (93). 
The expression mechanisms between the nonstructural replicase proteins and the structural 
proteins are fundamentally separated within the PRRSV genome facilitating rapid expression 
of nsps from the gRNA and subsequent amplification of sgRNA transcripts through a 
differential transcription cascade (94). sgRNA’s are synthesized by the viral RdRp through a 
highly ordered process encoded within the PRRSV genome. The set of nested (Nido Latin: 
nested) sgRNA’s encode noncontiguous gRNA sequence including both the 5’UTR and the 
polyadenylated 3’UTR as well as one or more ORFs from the 3’ region of the genome 
(ORF2-7) but lack the entire large ~12 Kb replicase coding region (ORF1a/b) (Figure 2.1) 
(26, 95, 96). It was originally hypothesized that nidoviral sgRNA’s could be generated 
through a free 5’UTR priming stage (97, 98) but was ultimately shown that nidoviruses 
utilize a discontinuous sgRNA transcription strategy (40, 99). Discontinuous replication 
proceeds through a replicative fusion of the viral genome 5’UTR to one of many downstream 
3’ sites through base pairing interactions between sense and antisense SL structures via long-
range RNA-RNA interactions (40) (Figure 2.3). Fusion is facilitated by a conserved 
sequence, the transcription-regulating sequence (TRS), located near the 3’ terminus of the 
5’UTR (Figure 2.4). An anti-sense TRS at or near the 5’ end of each structural protein coding 
region (ORF2-7) can each individually form a kissing-loop interaction with the leader-TRS 
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to prime transcriptional jumping. sgRNA’s synthesis and gRNA replication utilize a similar 
initial synthesis mechanism, whereby negative strand transcriptional extension from the 3’ 
termini is completed until a TRS signal sequence within the body of the genome is 
encountered (94, 100). The body TRS is ordered into a SL structure encoding a conserved 
heptanucleotide primary sequence (body TRS signal) (100) within the loop structure. This 
signal halts transcription of the negative strand and a ‘decision’ is made between 
transcriptional read-through and continuation of synthesis, or a disjoining of the 
transcriptional machinery and rejoining to the common leader TRS (antisense to body-TRS) 
by complimentary base-paring with a second SL structure within 5’ UTR (40, 101) (Figure 
2.3). The leader TRS is located within the 5’UTR directly upstream of the AUG start codon  
 
 
Figure 2.3. sgRNA synthesis. PRRSV structural proteins are translated from sgRNA’s. All structural protein 
coding regions are flanked upstream by transcription regulatory sequence (TRS) which are anti-sense 
complimentary to the leader TRS encoded within the 5’ UTR (102). sgRNA synthesis initiates as (-) strand 
replication (red) from the full length (+) sense (black) genome. RdRp interaction with a TRS either results with 
a read-through and a continuation of (-) strand replication or, in the case of sgRNA synthesis, disassociation of 
the replicating strain (body) and re-joining at the 5’ leader TRS (leader-body junction) through sequence 
complementarity annealing (red arrow) followed by completion of (-) strand sgRNA synthesis. All sgRNA’s 
possess identical 3’ and 5’ termini (see Figure 1-1). (-) sense sgRNA’s serve as template for generation of (+) 
sense sgRNA synthesis, required for structural protein translation.  
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of nsp1α and is part of a highly ordered and well conserved RNA secondary structure motif 
between the 5’UTR and the 5’ nsp1α coding region (Figure 2.4). Transcriptional read-
through of all body TRS sites will result in gRNA synthesis. Decoupling from the genomic 
strand at the body TRS and rejoining at the leader TRS results in noncontiguous transcription 
that lacks a large central region of the genome, yielding one of six sgRNA products 
(dependent on which body TRS is utilized) (65).  
 
Figure 2.4. The PRRSV 5’UTR Leader TRS. PRRSV replication proceeds by the transcriptional priming of 
the 5’UTR for full-length genomic replication and as a site of convergence (5’UTR leader TRS) for all 
discontinuous replication strategies (RNA 2-7). Predictions of RNA folding for the 5’UTR and the leader TRS 
were completed using the RNAfold prediction algorithm within the Geneious parental program (v6.1.6). 
Nucleotide bases are colored per predicted stability of base-pair interaction: red (high stability), green (mid 
stability), and blue (low stability). 5’UTR VR-2332 (U87392) 1-189nt; MN184C (EF488739) 1-190nt; SRV-07 
(JX512910) 1-189nt; JXwn06 (EF641008) 1-189nt; Lelystad (EU Prototype; M96262.2) 1-221nt). TRS 
secondary structure was demonstrated by predictive folding of the genomic region 124-249nt (VR-2332); 125-
250nt (MN184C); 124-249nt (SRV-07); 124-249nt (JXwn06); and 126-294nt (Lelystad). 
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While the mechanism of sgRNA generation is conserved, the discontinuous 
transcription process has been shown to be able to utilize both canonical and non-canonical 
body TRS sites and can have strain specific derivations (9, 64, 100). Alternative canonical 
and non-canonical body TRS sites often precede the coding region of PRSSV structural 
proteins, which function to drive sgRNA synthesis to various degrees of efficiency, yielding 
major and minor sgRNA species encoding the same structural protein. For instance, the NA 
PRRSV prototype strain (VR-2332) utilizes at least two different leader-body junction sites 
(AUAAC and UAAACC) for the generation of sgRNA7 sub-species (103). The 
mechanism(s) regulating sgRNA synthesis appear to be complex as shown by studies 
defining mutations within the EAV ORF7 body TRS (nucleocapsid) abolishing the 
generation of sgRNA7, the most abundantly produced sgRNA (40). Elimination of sgRNA7 
synthesis resulted in obvious increase in sgRNA6, 5, 4, and 2 but production of sgRNA3 
remained unchanged. Additionally, it was noted that a mutation within the leader TRS, 
altering the fifth nucleotide of the conserved sequence (5’-UCAAG-3’) eliminated synthesis 
of all sgRNA’s except sgRNA3 (40). This effect is due to a unique non-canonical TRS semi-
independent generation of sgRNA3.1, noted to be produced by both EAV and PRRSV (40, 
64). sgRNA3.1 uses a non-TRS body sequence of 5’-UCAAUACCC-3’ which lacks the 3’ 
terminal C residue of the canonical TRS sequence but possesses an additional five 
nucleotides (UACCC) that match the adjoining sequence downstream of the leader TRS, 
allowing for sense/antisense base pairing. (40).  
PRRSV EU prototype strain Lelystad virus (LV) sgRNA’s possess a conserved six 
nucleotide junction sequence of UCAACC (or similar sequence), but show heterogeneity at 
the junction site, suggesting the joining mechanism may be ‘imprecise’ (102). Studies on 
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whole RNA RT-PCR (cDNA) of virally infected cells with NA PRRSV strains further 
identified a similar common leader-body junction sequence U(G)UA(G/C)ACC (31, 64). 
Genetic heterogeneity was also noted at these junction sites, differing by a single base to a 
couple of nucleotides, showing there is slight flexibility within the disjoining and 
reattachment of the viral RdRp during this step (64). Data from single and double knock-out 
mutagenesis studies of alternative (non-canonical) TRS body sequences for EAV showed 
that the expression of solely the minor sgRNA species from alterative joining sites of the 
GP3, GP4, and GP5 structural proteins were sufficient for production of infectious progeny 
virus (93). It is not clear if the alternative TRS body sites serve as a secondary mechanism to 
rescue deleterious mutations from the error-prone RdRp, or if they serve a dedicated purpose 
within the viral life cycle. Knock-out of the canonical TRS body sequence of ORF3, 4, or 5 
resulted in infection rates at perceived wild-type levels (defined by IFA cell-to-cell spread; 1-
3 log PFU/ml reduction in titer) by utilizing secondary TRS sequences within these coding 
regions (93). Double knock-out mutants of both the canonical and accessory body TRS 
sequences surprisingly still resulted in generation of progeny virus, but at reduced levels 
(ORF3 = 2 log reduction, ORF4 = 3 log reduction, ORF5 = 5 log reduction; PFU/ml). It is 
presumed that even if the use of alternative TRS sequences results in inefficient sgRNA 
synthesis, the two amplification cycles (genomic RNA → (-) sense sgRNA synthesis → (+) 
sense sgRNA) may result in sufficient sgRNA copy numbers to allow a productive infection 
cycle to proceed. The authors noted that the reduction in PFU titers of the single or double 
TRS mutants corresponded “very well” to the reduction in molar ratios of each respective 
RNA subspecies (93).  
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Heteroclite RNAs 
Defective interfering (DI) RNAs are a normally observed by-product of (+) sense RNA virus 
replication, particularly under high multiplicity of infection (m.o.i.) culturing conditions 
(104-107). DI RNA’s are generated through non-homologous recombination between viral 
genomes resulting in random internal deletions but still encode the replication elements 
essential for generation of defective progeny virus including the genes encoding for the 
polymerase, essential replicase proteins, and capsid protein(s) (108). Unlike DI’s, a group of 
“heteroclite” sgRNA’s (heteroclite = deviating from common forms or rules) were identified 
within PRRSV replicative products of unusual structure but containing large internal 
deletions (108). Heteroclite sgRNA’s species were identified within infected cells, purified 
virions, porcine alveolar macrophages infected with field isolates under natural infection 
conditions, and within plaque-purified viral infections (108). The essential replicative 
products such as the viral RdRp were found to be absent within the heteroclite RNAs (108), 
discriminating them from prototypical DI genomes. Sequencing analysis showed a short site 
of three to seven conserved nucleotides between the 5’ and 3’ joining regions. The 5’ region 
of the heteroclites encoded terminal ORF1a proteins including one or more of the papain-like 
proteases and joined within the ORF6 coding region either in-frame or within alternative 
reading frames (108). These RNA species persist in a range of experimental culturing 
conditions including low m.o.i. passage and plaque purification (108) and were found to be 
packaged within the PRRSV virion (42, 109). Additional DI RNA that possess many similar 
genetic features have been identified but each contain a smaller deletion (nsp2-9) and encode 
all structural proteins (105). Currently there is no known function of heteroclite sgRNA’s but 
they have been proposed as a packaging vector to study the effect of viral factors, or the 
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effect of exogenous elements on viral replication, translation, progeny phenotype, or immune 
response/modulation (108).  
 
VIRION STRUCTURE 
 The PRRSV virion is a nondescript spherical particle roughly 60nm in diameter 
(Figure 2.5). The core of the particle is composed of the nucleocapsid protein (N), genomic 
viral RNA, and possibly cellular factors (45, 110). N protein assembles into a homodimer as 
the basic capsid unit and binds genomic vRNA via a set of positively charged residues within 
the N-terminal domain (47, 111). While it was originally believed the capsid formed 
icosahedral symmetry, structural studies have shown the vRNA is packaged into helical 
conformation (45). The fully package capsid-gRNA ultimately assembles to form a double-
layered hollow core superstructure of approximately 39nm in diameter (45). Surrounding the 
core is the viral envelope which maintains a 2-3nm gap between the core particle and the 
viral envelope on all sides (45). The viral envelope is composed of a spherical lipid bilayer 
sequestered from intracellular membrane structures of the porcine AMΦ, most likely derived 
from the ER or Golgi compartments (44). Embedded within the viral envelope are a number 
of viral protein complexes including the minor glycoprotein complex (GP2-GP3-GP4) and 
the major glycoprotein complex GP5-M heterodimer (44, 112). Both the major and minor 
complexes only extend a short distance from the exterior surface of the viral envelope (45), 
which gives the PRRSV virion a smooth appearance lacking any discernable outward 
projections (Figure 2.5). The small E protein (GP2b), dispensable for virion assembly but 
essential for infectivity, most likely forms ion channels within the viral envelope (putative 
viroporin), presumed to be critical to the pH dependent entry process of the PRRSV virus 
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(113, 114). An alternative reading frame within ORF5 also encodes a short 55aa protein 
(GP5a) packaged within the virion of PRRSV and of unknown function (42).  
 
 
Figure 2.5. The PRRSV virion. Highly pathogenic PRRSV strain SRV-07 imaged by transmission electron 
microscopy using an FEI Tecnai G2 transmission electron microscope operated at 80 kV (120,000x 
magnification). Difference in size and appearance of the PRRSV virion is noted between the use of common 
negative stains A) phosphotungstic acid and B) uranyl acetate.  
 
STRUCTURAL PROTEINS (STRUCTURE, FUNCTION, AND 
IMMUNOGENICITY) 
 Structural proteins formulate the viral encoded protein content of the virion and 
function in egress, attachment, entry, and/or early replication steps (115). PRRSV structural 
proteins are expressed by a highly ordered transcription/translation mechanism through the 
generation and amplification of sgRNA’s (see above). ORFs 2-7 encode the structural 
proteins of PRRSV within the final one-fourth of the viral genome and include GP2(a), E, 
GP3, GP4, GP5, GP5a, M, and N (Figure 2.1) (25, 112, 116).  
 
N 
The major structural elements comprising the virion are encoded with ORF5, 6, and 7 
(GP5, M, and N respectively) (117). The 15 kDa N phosphoprotein functions as a 
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homodimer via covalent disulfide linkage through the conserved cysteine residue at position 
23 (strain PA8) and by non-covalent interactions (47). The structure of the N dimer has been 
proposed to comprise a new class of viral capsid-forming domains and include antiparallel β-
strands that form a continuous, flat floor (possible internal surface of the capsid shell) with 
two long α-helices located above the β-strand floor flanked by N-terminal and C-terminal 
helices (48). N protein packages viral gRNA though interaction with positively charged 
residues within the N-terminal domain and accounts for as much as 40% of the protein 
content of the packaged virion (48, 118). N is highly antigenic and is a major immunological 
determinant of the humoral immune response to PRRSV infection (119-121). The humoral 
immune response to N is non-neutralizing and not protective against infection and may 
contribute to antibody-dependent enhancement of infection (119, 122). Intracellularly, N 
localizes to the nucleolus of infected cells at early time points post infection but migrates to a 
diffuse cytoplasmic pattern as the infection progresses (123). N is targeted to the nucleus by a 
nucleolar localization signal (NoLS). The function(s) of N within the nucleus is unknown but 
disruption of this targeting signal was shown to attenuate PRRSV replication (123, 124). N 
protein was found to interact with host nucleolin, importin-α and importin-β shuttle proteins 
presumably facilitating nuclear localization, and Fibrillarin and poly(A) binding protein 
(PABP) (125, 126); definitive functions of these interacting partners are yet to be determined.  
 
GP5 and M 
  The unglycosylated M protein and GP5 formulate the major constituents of the viral 
envelope (44). Residues 1-31 of GP5 (200aa; 25 kDa apparent MW) encode a membrane 
targeting signal cleavage sequence (49, 127); it has been recently shown that GP signal 
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sequence is cleaved in two locations, yielding a combination of differentially cleaved GP5 
within virions (127). GP5 encodes up to three additional membrane spanning helices between 
60-128aa which anchors the mature protein to the viral envelope. GP5 is heterogeneously 
glycosylated with complex N-linked glycans upon transfer to the medial Golgi compartment, 
a potential site of virion packaging (44, 128). A variable number of glycosylation sites within 
GP5 are located within the short ~30aa ectodomain of GP5 (31-60aa) which is a site of 
significant genetic heterogeneity between strains (49, 129). Genetic heterogeneity and 
differential glycosylation are believed to be major factors contributing to the lack of cross-
protection between PRRSV isolates (18, 127, 128). The final 70aa of GP5 (~130-200aa) is 
maintained within the internal compartment of the PRRSV virion.  
 The 174aa M protein also encodes three putative membrane spanning helices which 
are located between residues 16 to 94. Packaged M protein is predicted to display a short 
~16aa N-terminal ectodomain along with a large ~80aa C-terminal endodomain (130) and 
likely plays a key role in virion assembly (131). The M and GP5 heterodimeric complex is 
covalently linked by a disulfide bond presumably between conserved cysteine residues 
within the N-terminal ectodomains of each protein (44). The M-GP5 major glycoprotein 
complex functions in critical low-affinity binding interactions with the porcine AMΦ surface 
receptors heparin sulfate and sialoadhesin to initiate viral entry (132, 133). Neutralization 
epitopes are identified within the ectodomain of GP5 and are correlated with glycosylation 
sites (134-137), although a low quality humoral immune response including minimal serum 
neutralization titers are typical with PRRSV infection (138, 139). The M-GP5 dimer has been 
also shown to be critical for virion formation (46) and mutation of some N-glycosylation 
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sites of the GP5 ectodomain results in viral attenuation (128, 140) suggesting a role for these 
glycosylation sites in virion maturation or entry.  
 
E, GP2, GP3 and GP4 
 GP2, GP3 and GP4 comprise the ‘minor’ heterotrimeric glycoprotein complex 
covalently attached by disulfide linkages (141). GP2 is a 30kDa integral membrane protein 
encoded by 256aa (NA) and 249aa (EU) (112, 131). GP2 possesses an N-terminal signal 
peptide (~40aa), a central 168aa ectodomain, a single transmembrane anchor domain and an 
approximately 20aa endodomain (112, 142). GP2 encodes two highly conserved putative N-
linked glycosylation sites within the ectodomain (N173 and N178; EU LV strain) which are 
non-essential for virion formation or infectivity (142). In one study defining B-cell epitopes 
of PRRSV, two epitopes of GP2 comprised of regions 41-55aa and 121-135aa of an NA 
strain (NVSL 97-7895) were recognized by 60% (9/15) of sera from PRRSV infected hosts 
(143) demonstrating GP2 is commonly recognized by the humoral immune response to 
infection. The ultimate antigenicity of a broader class of PRRSV strains, or the significance 
of immune responses targeting GP2 is however currently unknown (143). The small E 
protein, encoded within an embedded ORF (2b) inside the GP2a gene, was defined above. 
Additionally, the myristoylated E protein (70-73aa) may also be a critical component of the 
minor glycoprotein complex (144). At least one study reported that E interaction with the 
GP2-GP3-GP4 complex was essential for packaging of the minor glycoprotein complex 
(145). 
 GP3 is a 254aa (NA) or 265 (EU) protein with an apparent molecular weight of 
45kDa (112, 146). The topology of GP3 is currently unknown but may encode two 
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transmembrane domains, one predicted to be located on the N-terminus (1-27aa; possibly 
cleaved) and the other near the C-terminal domain (~182-201aa) (147). GP3 was originally 
thought to be a secreted nsp of PRRSV since GP3 was expressed to similar levels at GP5, M, 
and N in the infected cell, was originally not detected in the PRRSV virion, and a soluble 
form (sGP3) was identified (146, 148). Further analysis demonstrated GP3 as a structural 
micro-component of the virion (149). GP3 is predicted to be heavily glycosylated, encoding 
as many as seven putative N glycosylation sites (146). The disparity between the calculated 
molecular mass of GP3 (~27kDa) and the apparent molecular weight as defined by SDS-
PAGE analysis (43-45kDa) (112, 146) suggests that all seven glycosylation sites are used. 
GP3 is noted as a major site of genetic heterogeneity between strains and is the second most 
genetically variable structural protein of PRRSV (49).  
 The 178aa (NA) or 183aa (EU) GP4 protein is predicted to encode four N 
glycosylation sites within the ectodomain (22-156aa) (41). Like GP2 and GP3, GP4 is 
predicted to encode N-terminal (~1-22aa) and C-terminal (156-178aa) transmembrane 
spanning domains (41) whereas the N-terminal transmembrane domain is a putative signal 
cleavage peptide (150). Along with GP5, humoral immune responses targeting the GP4 
protein have neutralizing potential (150). The linear neutralization epitope (59-70aa; N-
SAAQEKISF-C) of GP4 is located within the hypervariable region of this protein (150). Due 
to the high mutation frequency of this region, neutralizing antibodies targeting GP4 appear to 
protect against homologous challenge but not heterologous isolates (150, 151). In vitro 
passage with suboptimal doses of neutralizing antibody showed that GP4 is susceptible to 
rapid immunoselection within the neutralization domain (152) and has been suggested to be a 
major determinant to PRRSV evolution (153). While immune responses generated against 
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GP4 are protective, one report using a panel of monoclonal antibodies showed that genetic 
subpopulations (quasispecies (20)) of single PRRSV isolates induce differential neutralizing 
capacity (154) which illustrates the complex nature of PRRSV host-pathogen interactions.  
 Together, the PRRSV minor glycoprotein complex functions to facilitate viral entry 
into the porcine AMΦ. Both GP4 and GP2 function to bind CD163 (41, 155), the PRRSV 
entry receptor (156). CD163 expression is restricted to cells of the monocyte lineage (157, 
158) functioning physiologically as a haptoglobin scavenger receptor (159). Interaction of the 
minor glycoprotein complex with CD163 is most likely the defining characteristic conferring 
the highly restricted tissue tropism of PRRSV for cells of the monocyte lineage. Generation 
of chimeric viruses expressing the EAV minor glycoprotein genes (GP2, GP3, GP4), which 
has a broad tropism, within a PRRSV genetic backbone resulted in an equally broad in vitro 
tissue tropism (160) demonstrating the role of the minor glycoprotein complex in defining 
tissue tropism of PRRSV. Functionally, engagement of GP4/GP2 with CD163 initiates a 
clathrin-dependent receptor-mediated endocytosis of the PRRSV virion (156, 161), 
functioning as the primary entry mechanism for PRRSV infection (156, 162). 
 
NONSTRUCTURAL PROTEINS 
 The PRRSV replicase nsp performs a variety of functions relating to the modulation 
of the host cellular environment, immunoregulation/immunoinhibition, and viral replication 
(39). Polyprotein precursors are translated from gRNA and co-translationally and post-
translationally processed by viral encoded proteases into at least 14 distinct nsp products 
including nsp1α, nsp1β, nsp2-6, nsp7α/β, and nsp8-12 (25). The mature PRRSV replicase 
proteins encompass a large size range from 16aa (nsp6; 1.7kDa) to 1196aa (nsp2; 129kDa). 
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ORF1a 
 Nsp1α and nsp1β each encode papain-like cysteine proteases (PLP) (163). PLPs are 
characterized by a catalytic dyad composed of a nucleophilic cysteine residue and a 
downstream histidine residue (164, 165). The putative catalytic dyad of nsp1α is located at 
cysteine 76 (C76) and histidine 146 (H146), although H115 or H157 could also participate 
(166). PLP1α and PLP1β perform the essential functions of cleaving the nsp1α180↓nsp1β 
(167) and nsp1β383↓nsp2 junctions (166). Nsp1α forms dimers both in solution and in crystals 
and structural analysis suggests that PLP1α most likely performs cis cleavage of the 
nsp1α180↓nsp1β (167). Mutation of either H115 or H157 of nsp1α resulted in a reduction but 
not elimination of nsp1α//nsp1β processing whereas amino acid substitution of either C76 or 
H146 completely abolished proteolytic activity in vitro (166). Mutations that eliminated 
PLP1α proteolytic activity also eliminated sgRNA synthesis (166). Nsp1α also encodes a 
putative zinc finger motif through four cysteine residues (C8, C10, C25, C28; EU genotype) 
that is a common feature of transcription factors (168), potentially important for regulation of 
sgRNA synthesis (168). Mutation of PCP1β catalytic dyad C276 and H345 completely 
inactivated protease activity, gRNA synthesis and sgRNA transcription (166) defining the 
requirement of both nsp1α and nsp1β processing for PRRSV replication. In addition, nsp1α 
and nsp1β have been shown to interfere with the innate antiviral immune response through 
multiple mechanisms including inhibiting interferon (IFN) regulatory factor (IRF3) and 
nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) signaling (169, 170), 
through interfering with IRF3/cAMP response element-binding protein (CREB) binding 
protein (CPB) interaction and increasing proteasome-depended degradation of CPB (171), 
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and inhibition of STAT nuclear translocation (172). Nuclear localization (172, 173), 
functionality of the nsp1α zinc finger motif (174) and PLP1α protease (175), and 
maintenance of a highly conserved sequence (GKYLQRRLQ) in nsp1β (176) were all 
reported to be important for the knock-down of pathogen recognition receptor (PRR) 
signaling and inhibition of type I IFN production.  
 Nsp2 performs a variety of functions related to virion replication, polyprotein 
processing, and immunosubversion and will be discussed in greater detail below. Nsp2, nsp3, 
and nsp5 each encode hydrophobic domains that integrate within the ER membrane at the 
site of replication (67). Nsp3 and nsp5 are almost entirely comprised of hydrophobic domains 
(putative multi-pass transmembrane helices) and thus the functionality of these proteins are 
most-likely tightly associated with membrane associated functions (177). While the 
functionality of nsp5 is largely unexplored, nsp3 was found to be critical to the formation of 
DMV RC’s (69). Mutation of a core set of four conserved cysteine residues located within 
the ‘luminal loop’ of the ER dramatically affected DMV formation and resulted in a 
nonviable phenotype (178).  
 The nsp4 3C-like main serine protease (SP) is defined by a His39-Asp64-Ser118 
catalytic triad common to serine proteases, but shares substrate binding similarities with the 
picornavirus 3C-like cysteine proteases (179). The nsp4 SP is folded into three domains: an 
N-terminal β-barrel, a central β-barrel, and a C-terminal α/β domain (179). The catalytic 
active site is located in the cleft between domains I and II (179) and domain III forms a 
putative hinge region possibly allowing regulatory function of the SP (180). SP functions to 
cleave all nsps downstream of the nsp2↓nsp3 junction (86) and has been shown to have cis- 
and trans- cleavage activities (179). Processing of the pp1a/b by SP can occur by differential 
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processing cascades, depended on nsp2 function as a molecular switch (181). The functions 
relating to nsp5-8 are currently unknown (28). The largest of the four proteins, nsp7 (256aa), 
is cleaved into two components nsp7α and nsp7β (180, 182). Structural studies of nsp7 
identified a ‘unique fold’ which did not share any similarity to other characterized tertiary 
structures (183). While no functional motifs have been identified, mutational analysis 
showed that nsp7 was essential to PRRSV replication (184).  
 
ORF1b 
 The functions relating to ORF1b proteins have been discussed previously and include 
the critical replicative machinery supporting PRRSV replication including the RdRp (nsp9) 
and helicase (nsp10). Nsp11 encodes the poorly characterized nidoviral uridylate-specific 
endoribonuclease (NendoU). The NendoU endoribonuclease cleaves internal segments of 
dsRNA in a sequence specific manner by targeting uridylates at GU(U) positions to yield 2’-
3’ cyclic phosphate ends (185). The viral NendoU is the most similar to the cellular homolog 
XendoU endoribonuclease family that participates in ribosomal preRNA processing 
pathways (186). The active site of the arterivirus NendoU is composed of a catalytic triad 
(His-126, His-141, and Lys-170; EAV) and closely resembles the active site of RNase A 
(187). Unlike the coronavirus NendoU, the arterivirus homolog does not require a divalent 
cation (MN
2+
) for catalytic activity (185, 187). The function of the NendoU cleavage activity 
is currently unknown but mutation of the active site abolishing endoribonuclease activity is 
lethal for nidoviruses including PRRSV (187).  
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The Multifunctional Nsp2 
 The nsp2 protein is unique among the PRRSV genome due to its large size, 
significant genetic heterogeneity, accessory functions of the PLP2 protease, novel RFS, the 
generation of a large class of isoforms, and its biophysical characteristics among virally 
encoded putative transmembrane proteins (36, 38, 39, 188-191). Nsp2 is comprised of three 
domains including an N-terminal protease domain (PLP2), a large central hypervariable 
domain (HV) of unknown function, and a relatively well conserved C-terminal domain 
including a C-proximal hydrophobic region (putative transmembrane domain). The 1196aa 
nsp2 (NA VR-2332) is the largest protein encoded within the PRRSV genome; for reference, 
the second largest protein [the RdRp] is 685aa in length and 90% of the remaining proteins 
encoded within the PRRSV genome are 255aa or under (data not shown). Nsp2 is also the 
most genetically divergent coding region of the PRRSV genome, sharing as little as 32% aa 
sequence identity between strains (192). The majority of the mutation frequency noted within 
nsp2 occurs inside the large central HV region and includes a range of insertions, deletions, 
and nucleotide substitutions (188, 193-195). The driving selective pressure of nsp2 is 
unknown. It has been shown that large sections of the HV region of nsp2 are dispensable for 
replication in vitro (196) and in vivo (197). Due to the plasticity of the genome within this 
region it has been postulated that nsp2 may be an ideal location for the insertion of foreign 
epitope tags for the tracking and identification of PRRSV strains including vaccines (198-
201).  
 The PLP2 core protease domain (47-180aa; NA) possesses the canonical catalytic 
dyad C55 and H124 typical of papain-like proteases but differs in that a non-bulky glycine 
(G) residue is located at position 56 whereas a tryptophan is typical at this position (202, 
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203). The PLP2 protease functions to cleave the nsp2↓nsp3 junction and possesses both cis- 
and trans-cleavage activities (202, 203). The PLP2 protease domain additionally displays 
deubiquitinating (DUB) accessory functionality (189). The arterivirus DUB activity functions 
to counteract ubiquitin (Ub) specific antiviral immune responses (191, 204). The arterivirus 
DUB has been shown to be able to remove both Ub and Ub-like substrates (ISG15) (205) 
however the PRRSV DUB activity appears to be limited to Ub substrates in vitro (206). 
Further, analysis of low and high pathogenicity PRRSV isolates showed different cleavage 
rates of both di-Ub and poly-Ub K-63 substrates (206). The arterivirus DUB enzyme was 
shown to knock-down type I IFN signaling nearly 10-fold, demonstrating the 
immunosuppressive activity of the PLP2 DUB (191). 
 The noted hydrophobic region of nsp2 is predicted to encode a multi-pass 
transmembrane domain. Nsp2, along with nsp3 and nsp5, comprise the putative replicase 
transmembrane proteins. Unlike nsp3 and nsp5, nsp2 possesses a large hydrophilic N-
terminal domain (PLP2 and HV) that is known to participate in non-membrane viral 
replication functions including polyprotein processing and immunosubversive activities (191, 
203). Recombinant expression of nsp2 and nsp3 of EAV were shown to be sufficient to 
modify host ER membranes into RC DMV-like structures (69). Additionally, nsp2 was 
shown to participate in polyprotein processing by the main SP, functioning as a molecular 
switch dictating between ‘major’ and ‘minor’ differential processing cascades of nsp5-8 
(181). The functionally of the putative transmembrane domain of nsp2 remains unexplored; 
however, nsp2 is predicted to function in connection with nsp3 and nsp5 to tether the co-
translational and post-translational processing of the large replicase polyproteins at the site of 
replication (DMVs) (69, 181).  
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 In addition to alterative processing of the pp1a, nsp2 is also differentially expressed 
and modified at the translational and post-translational level (36, 190). As noted previously, 
encoded within the nsp2 gene is a unique -2 RFS site (36) that is expressed through an 
equally unusual protein transactivation mechanism (nsp1β; (38)). -2 RFS (16-20% 
efficiency) and -1 RFS (~7% efficiency) result in the expression of either nsp2-TF (36) or 
nsp2-N (38), respectively. The -1 RFS results in an immediate translation termination while 
the -2 RFS yields a translational extension within the -2 frame of 513nt (170aa). The function 
of these truncated nsp2 translational isoforms is currently unknown. The generation of post-
translational (cleavage) isoforms has also been described for nsp2 (190). The mechanism of 
generation of these cleavage isoforms has not been defined and may include proteolytic 
cleavage by either cellular or viral proteases. The PLP2 protease preferentially cleaves GG 
dipeptides (202). GG residues are encoded within multiple regions within nsp2, three of these 
sites display ≥97% conservation (% pairwise identity) between 283 non-identical PRRSV 
genomes including NA and EU isolates (data not shown). At least six cleavage isoforms 
(nsp2a-f) were originally identified, however, the genetic composition of these isoforms 
remains unknown (190).  
 A robust humoral immune response is generated against nsp2, similar to the 
magnitude of the response generated against the immunodominant N protein (207). Multiple 
B-cell epitopes have been identified within the nsp2 coding region (208, 209). Deletion of 
these epitopes was not lethal for the virus but some of these deletion mutants displayed 
reduced growth kinetics and lower cytotoxicity profiles (210). Putative T-cell epitopes have 
also been defined within the nsp2 (188). A strong humoral immune response against nsp2 is 
somewhat surprising since it has no known extracellular function or localization, and the 
38 
 
response appears early in infection (211). Understanding the mechanism(s) contributing to 
recognition of nsp2, and further the impact of these immune responses on viral infection, 
may both help explain the high mutation rate of this region of the genome and additionally 
define molecular targets important to design of antiviral therapeutics.  
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ABSTRACT 
Viral structural proteins form the critical intermediary between viral infection cycles within 
and between hosts, function to initiate entry, participate in immediate early viral replication 
steps, and are major targets for the host adaptive immune response. We report the 
identification of nonstructural protein 2 (nsp2) as a novel structural component of the porcine 
reproductive and respiratory syndrome virus (PRRSV) particle. A set of custom α-nsp2 
antibodies targeting conserved epitopes within four distinct regions of nsp2 (the PLP2 
protease domain [OTU], the hypervariable domain [HV], the putative transmembrane domain 
[TM], and the C-terminal region [C]) were obtained commercially and validated in PRRSV-
infected cells. Highly purified cell-free virions of several PRRSV strains were isolated 
through multiple rounds of differential density gradient centrifugation and analyzed by 
immunoelectron microscopy (IEM) and western blot assays using the α-nsp2 antibodies. 
Purified viral preparations were found to contain pleomorphic, predominantly spherical 
virions of uniform size (57.9 nm ± 8.1 nm diameter; n =50), consistent with the expected size 
of PRRSV particles. Analysis by IEM indicated the presence of nsp2 associated with the 
viral particle of diverse strains of PRRSV. Western blot analysis confirmed the presence of 
nsp2 in purified viral samples and revealed that multiple nsp2 isoforms were associated with 
the virion. Finally, a recombinant PRRSV genome containing a myc-tagged nsp2 was used to 
generate purified virus, and these particles were also shown to harbor myc-tagged nsp2 
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isoforms. Together, these data identify nsp2 as a virion-associated structural PRRSV protein 
and reveal that nsp2 exists in or on viral particles as multiple isoforms. 
 
INTRODUCTION 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the cause of a 
complex systemic disease of swine, most notably affecting the respiratory and reproductive 
systems of infected hosts. PRRS is characterized by an acute viral infection of the porcine 
macrophage that leads to an immunologically altered state. In extreme cases, respiratory 
distress, metabolic dysregulation, and neuronal involvement result in significant mortality 
within days to weeks of experimental inoculation with highly pathogenic isolates (1, 2). 
Endemic disease from emerging and reemerging PRRSV results in estimated annual 
economic losses totaling greater than 560 million dollars, or $1.5 million per day, to the US 
economy alone (3, 4).  
A key hurdle to PRRSV investigation has been the difficulty in ascribing conserved 
functional characteristics to virally encoded nonstructural proteins. This hurdle is largely 
rooted in the significant genetic heterogeneity noted among strains, genotypes, and viral 
species of the family Arteriviridae and, more broadly, the order Nidovirales that also 
encompasses Coronaviridae and Roniviridae. Through the combined effects of a highly error 
prone viral RNA dependent RNA polymerase (RdRp) and a significant rate of genetic 
recombination, the evolution rate of PRRSV (4.71-9.8 X 10
-2
 synonymous substitution 
rate/site/year) is estimated to be nearly 10-fold higher than those of human 
immunodeficiency virus (HIV) or influenza virus (5-9). The narrative of the last two decades 
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of PRRSV investigation has demonstrated the robust nature of PRRSV to undergo 
extraordinary genetic change while maintaining pathogenicity.  
A significant fraction of attenuating and naturally occurring mutations have been 
observed within the region of the replicase nonstructural protein 2 (nsp2) (10-12). Nsp2 is 
encoded by 21-23% of the genome and consists of a papain-like protease domain (PLP2) 
near the amino terminus that has been shown to be a member of the ovarian tumor domain 
protease (OTU) family (13-16). The nsp2 PLP2/OTU region is followed by an extended 
central hypervariable (HV) region with strain-specific insertions or deletions, a putative 
transmembrane region (TM) that is predicted to encode up to five membrane-spanning 
regions, and a relatively conserved carboxyl (C-terminal) domain. Previous reports suggest a 
multifunctional role of nsp2 in critical replication and immune evasion functions (14-20). 
Nsp2 is both the largest and most genetically diverse protein encoded within the PRRSV 
genome. The elevated frequency of mutation and recombination within the nsp2 coding 
region suggests there is significant selective pressure(s) placed against nsp2 genetic or 
protein content (17, 21, 22). Interestingly, whereas current data only support an intracellular 
role for nsp2 (19, 23-26), a strong antibody response is generated against nsp2 during the 
course of natural infection (27). Nsp2 is recognized as an immunodominant target of the 
adaptive immune response resulting in significant anti (α)-nsp2 titers comparable to the 
response generated against the highly abundant/highly immunogenic nucleocapsid protein 
(N) (27, 28). Moreover, various B-cell and T-cell epitopes have been bioinformatically or 
experimentally defined within the nsp2 coding region (21, 29, 30). These attributes suggest 
nsp2 might also maintain an extracellular localization or function during the viral replication 
cycle. Similarly, recent findings have described the incorporation of a PRRSV nsp2 
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orthologue, nsp3, into to the virion of the related Coronaviridae including severe acute 
respiratory syndrome virus (SARS) and transmissible gastroenteritis coronavirus (TGEV) 
(31, 32). In this report, we investigated the association of PRRSV nsp2 with the virion and 
provided evidence that nsp2 is a novel structural protein of the PRRSV particle. This finding 
was conserved across a range of five genetically diverse PRRSV strains including the 
European (Type 1) and North American (Type 2) prototype strains Lelystad (33) and VR-
2332 (34, 35), respectively, a disparate Type 2 strain MN184 (12), as well as the Asian 
highly pathogenic PRRSV (HP-PRRSV) strains rJXwn06 (2) and rSRV07 (36) (Table 3.1). 
The presence of nsp2 in/on virions indicates a plausible immediate-early function of this 
protein within the viral life cycle and importantly, virion-associated extracellular localization 
may also contribute to the high selective pressure driving nsp2 genetic diversity.  
 
MATERIALS AND METHODS 
Antibodies. Custom affinity purified polyclonal antibodies (rabbit) to PRRSV nsp2 included 
α-nsp2-OTU (OTU domain; epitope SKFETTLPERVRPP), α-nsp2-HV (hypervariable 
region; epitope TRPKYSAQAIIDSG), α-nsp2-TM (transmembrane region; epitope 
SDPVGTACEFDSPE), and α-nsp2-C (C-terminal region; epitope NGLKIRQISKPSGG) 
(GenScript, Piscataway, NJ). Prior to western blot probing, α-nsp2 antibodies were cross-
absorbed with uninfected MARC-145 cell lysate for ≥1 hour at 37°C to eliminate potential 
cross-reactivity with cellular products. Epitope sites were chosen based on predicted 
antigenicity [proprietary algorithm, Genscript, Piscataway, NJ], sequence conservation in the 
five study strains, and epitope location within the nsp2 coding region.  
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Immunofluorescence analysis. MARC-145 cells were seeded at a density of ~5 X 10
4
 
cells/cm
2
 and allowed to incubate for 2-3 days prior to infection in 1X minimum essential 
medium (MEM; SAFC Biosciences, Lenexa, KS) supplemented with 2.2% w/v sodium 
bicarbonate, 11% w/v sodium pyruvate (Life Technologies, Carlsbad, CA) and 10% fetal 
bovine serum [bovine viral diarrhea virus-free] (FBS; PAA Laboratories, GE Healthcare Bio-
Sciences Corp, Piscataway, NJ). Monolayers were inoculated with passage 5 of VR-2332 at 
an M.O.I. of 0.1 and the infections were allowed to progress for 48 hours. At 48 hours post 
infection (h.p.i.), supernatants were removed and the monolayers were washed in phosphate 
buffered saline (10 mM Na2HPO4/KH2PO4, 137 mM NaCl, pH 7.4; PBS) prior to fixation 
with a 4% solution of paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in 
PBS, followed by permeabilization with a 0.2% solution of Triton-X 100 (Sigma-Aldrich, St. 
Louis, MO) in PBS. Fixed and permeabilized monolayers were analyzed by indirect 
immunofluorescence using the primary antibodies α-nsp2-OTU (1:100), α-nsp2-HV (1:100), 
α-nsp2-TM (1:50), and α-nsp2-C (1:50), or α-N SDOW-17-A (mouse) 1:50 (Rural 
Technologies Incorporated, Brookings, SD) followed by detection with the secondary Alexa 
Fluor® 546 goat α-rabbit IgG (H+L) (Invitrogen, Carlsbad, CA) [at a final concentration of 
80µg/ml (1:25 dilution in PBS)] and FITC conjugated α-mouse IgG (Sigma-Aldrich, St. 
Louis, MO) (1:12.5 dilution in PBS). Images were acquired with the Leica DM IRBE 
microscope in connection with the Leica DFC500 digital camera and the Leica Application 
Suite (v3.7.0) at magnifications between 200X and 400X.  
Virus purification. For the generation of purified viral stocks used in this study, low passage 
(≤15 passages) MARC-145 cells were seeded at a density of ~5.0 X 104 cell/cm2 and allowed 
to incubate for three days in 1X MEM prior to inoculation. Low passage viral stocks (passage 
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5 or below) of field isolates VR-2332 (U87392), recombinant (r) rJXwn06 (EF641008), 
rSRV07 (JX512910), MN184C (EF488739), Lelystad virus (M96262), and a rVR-2332 
strain (rV7) encoding a myc-tag in the hypervariable region of nsp2 (rV7-myc) (FJ524377)  
 
Table 3.1. Description of study strains 
Strain Description 
Lelystad European (Type 1) prototype strain (1991) 
VR-2332 North American (Type 2) prototype strain (1989) 
rV7-myc Recombinant VR-2332 expressing a 3X c-myc epitope tag within nsp2  
MN184C Regional North American isolate (2001) 
rJXwn06 Chinese Highly Pathogenic PRRSV isolate (2006) 
rSRV07 Vietnamese Highly Pathogenic PRRSV isolate (2007) 
 
(37) were used to infect confluent MARC-145 monolayers (2500 cm
2
 per isolate) at a 
multiplicity of infection (M.O.I.) of 0.1 and maintained at 37°C and 5% CO2 until 60-80% 
cytopathic effect (CPE) was reached (roughly two days). Please refer to previous publication 
for analysis of the growth kinetics for each study strain (36, 38, 39). Cell supernatants were 
collected and clarified at 5,000 x g, 4°C, for 1 hour to remove non-adherent cells and large 
cellular debris prior to downstream purification of cell-free virions. The resulting clarified 
viral supernatants were pelleted through a sterile 0.5 M sucrose in TNE buffer (10mM Tris-
HCL (pH7.0), 0.1M NaCl, 1mM EDTA) cushion at 104,000 x g for 3-4 hours at 4°C to 
selectively exclude the pelleting of viral and cellular components < 1g/ml density. Viral 
pellets were gently reconstituted in low volumes of TNE buffer prior to overlaying on top of 
1.29g/ml density cesium chloride (CsCl) (optical grade; Life Technologies, Carlsbad, CA) in 
TNE buffer and subjected to banding at 151,000 x g for 12-24hr at 4°C. Viral bands were 
collected by side tapping with a sterile needle followed by a second round purification 
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through CsCl gradient banding (2X CsCl). 2X CsCl purified virus was diluted 10-fold in 
TNE buffer and pelleted at 151,000 x g for 2hr at 4°C. Final purified viral pellets were eluted 
in low volumes TNE buffer in 10% protease inhibitor cocktail (P8340, Sigma-Aldrich, St. 
Louis, MO) and subjected to downstream analysis by immunoelectron microscopy and 
western blotting. Alternatively, after the initial pelleting step through the 0.5M sucrose 
cushion, viral and mock isolates were purified by semi-discontinuous sucrose gradients 
generated as previously described (40). Since a viral band was not visible by sucrose 
purification, final samples were collected by side-tapping the sucrose gradients and collecting 
density ranges between the 20% and 30% sucrose + TNE, estimated to contain the density 
range of the PRRSV virion (1.18-1.19g/mL, (35)).  
Immunoelectron microscopy. To prepare purified samples for immunoelectron microscopy, 
a small volume of each purified PRRSV preparation (5-10µL) was chemically cross-linked 
using electron microscopy grade paraformaldehyde (PFA) at a final concentration of 4% for 
5 min at room temperature (Electron Microscopy Sciences, Hatfield, PA) to maintain the 
integrity of the virion during processing. Fixed samples were loaded onto Nickel Formvar 
support grids (Electron Microscopy Sciences, Hatfield, PA), and remaining reactive 
aldehydes were inactivated by treatment of the grids with 0.5M glycine in PBS followed by 
blocking overnight with 1% bovine serum albumin (BSA; CAS 9048-46-8, Sigma-Aldrich, 
St. Louis, MO) in PBS at 4°C. Immunodetection of virions was accomplished by probing 
with primary α-nsp2 antibody, diluted in 1% BSA in PBS at a final dilution of 1:100 (2 hours 
at 4°C), and the secondary antibody goat α-rabbit conjugated to 1-6nm colloidal gold (CG), 
used at 1:10 dilution (Electron Microscopy Sciences, Hatfield, PA) (4°C for 30 minutes). 
After each antibody incubation step, grids were washed a minimum of 4 times for 5 minutes 
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with 1% BSA in PBS at room temperature. Probed samples (grids) that were labeled with 
1nm CG were further processed with the Aurion R-gent SE-EM high efficiency silver 
enhancement system per manufacturer’s instructions (Electron Microscopy Sciences, 
Hatfield, PA) to increase visibility, resulting in large, slightly pleomorphic punctate label of 
varying size greater than the original 1nm diameter (at times larger than 20nm). Samples 
labeled with 6nm CG were not silver-enhanced. Images were acquired using the FEI 
Tecnai™ G2 transmission electron microscope operated at 80Kv with a Hamamatsu 
Photonics ORCA-HR digital CCD camera in conjunction with the FEI Tecnai™ G2 software 
platform.  
Western blot analysis. Purified virus samples were resolved under reducing and denaturing 
conditions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 
4-12% Bis-Tris Novex NuPage® gels in conjunction with the XCell Surelock® mini-cell 
electrophoretic module with 2-(N-morpholino)ethanesulfonic acid (MES) running buffer per 
manufacturer’s instructions (Life Technologies, Carlsbad, CA). Resolved proteins were 
transferred to nitrocellulose membranes for western blot detection by the iBlot dry transfer 
system (Life Technologies; Carlsbad, CA) and blocked at room temperature for ≥1hr in 5% 
dehydrated milk (w/v) in PBS/0.05% Tween 20 (PBST) with shaking. Nsp2 detection 
proceeded by probing with the primary α-nsp2 antibodies (OTU) and (HV) (rabbit), or the α-
myc monoclonal antibody 9E10 (mouse) (Developmental Studies Hybridoma Bank, 
University of Iowa, IA), diluted in filtered 5% milk in PBST at a ratio of 1:1000 (α-nsp2 
antibodies) or 1:1500 (9E10) overnight at 4°C while rocking, followed by the secondary goat 
α-rabbit conjugated horseradish peroxidase (HRP; IgG H+L chain, SouthernBiotech, 
Birmingham, AL) or the goat α-mouse conjugated horseradish peroxidase (Santa Cruz 
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Biotechnology, Dallas, TX) antibody diluted in filtered 5% milk in PBST at a ratio of 1:2500 
incubated overnight at 4°C while rocking. To detect nsp2 isoforms, Western blots were 
treated with the chemilumininescent/chemifluorescent ECL Plus substrate (Pierce, Rockford, 
IL) and imaged by chemilumininescent film (Kodak, Rochester, New York) or by digital 
capture (G:BOX Chemi XT4, Syngene, Frederick, MD). 
 
RESULTS 
Characterization of intracellular nsp2 during PRRSV infection. Polyclonal affinity-purified 
anti-peptide antibodies were produced in rabbits against four different regions of the nsp2 
protein, denoted as -nsp2-OTU (VR-2332 aa 69-82), -nsp2-HV (VR-2332 aa 633-646), -
nsp2-TM (VR-2332 aa 630-643) and -nsp2-C (VR-2332 aa 1183-1196) (Fig. 3.1). The 
selected epitopes represented conserved regions of the PRRSV strains examined, except for 
Type 1 strain Lelystad in some cases. Three antibodies, -nsp2-OTU, -nsp2-HV and -
nsp2-C, were found to specifically stain PRRSV-infected MARC-145 cells (200X) in 
primarily perinuclear regions and did not cross-react with any uninfected cell component 
(Fig. 3.2A). However, in a subset of infected cells, a diffuse punctate pattern, characteristic 
of ER/Golgi compartments, was evident throughout much of the cell by -nsp2-OTU 
staining at higher magnification (400X) (Fig. 3. 2B). A similar staining pattern was noted 
with the α-nsp2-HV antibody, although to a lesser extent, and the bulk of staining was 
localized to the perinuclear region (Fig. 3.2A and B). Nsp2 was not detected by the α-nsp2-
TM antibody by IFA (Fig. 3.2A and B); perhaps because this region is predicted to be 
embedded in the membrane, rendering the epitope inaccessible under the experimental 
conditions used, or the antibody itself was ineffective. Finally, -nsp2-C detection localized 
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primarily to regions directly surrounding the cell nuclei (Fig. 3.2A and B). Surprisingly, in 
some cases, nsp2 densely localized to long cellular extensions as detected by each of the 
three antibodies (Fig. 3.3A). These extensions extend the length of two or more cells and are  
 
Figure 3.1. Peptide sequence alignment of nsp2. The nsp2 peptide sequence from genetically diverse study 
strains of PRRSV including the European Type 1 prototype Lelystad virus and the North American Type 2 
prototype strain VR-2332, the regional North American strain MN184, and the Asian highly pathogenic PRRSV 
isolates rJXwn06 (China) and rSRV07 (Vietnam) were aligned using the ClustalW algorithm (41) in the parent 
program Geneious 6.1.5 (Biomatters Limited) and transferred to Jalview 2.8 (42) for percentage identity 
coloring. Intensity of shading depicts the level of sequence similarity between strains; the darkest shaded areas 
represent a fully conserved residue or region, no shading represents a low level of sequence conservation at that 
position. Alignment regions are shown for each epitope sequence targeted by custom α-nsp2 antibodies. Linear 
epitope sequence range denoted above alignment in reference to the VR-2332 nsp2 protein sequence (AA = 
amino acid). Diagram of nsp2 in reference to VR-2332 nsp2, PLP2 (Papain like Protease 2/OTU enzymatic 
domain); HV (large central hypervariable region); TM1-4 (hydrophobic region, predicted transmembrane 
regions 1-4).  
 
found to possess moderate to high intensity nsp2 detection along the length of the filament. 
PRRSV nucleoprotein (N) co-localized with nsp2 at the greatest intensity at the perinuclear 
regions of virally infected cells. N was additionally identified to localize to a lesser extent 
near the distal and proximal regions of the nsp2 cellular projections (Fig. 3.3B). 
Procedural validation of PRRSV particle purification. Viral supernatants were generated 
from low M.O.I. infections and were harvested prior to any overt destruction of the cellular 
monolayer or cellular necrosis (60-80% CPE, 0-5% monolayer detachment [by surface 
area]), thereby limiting release of any cellular nsp2 into the supernatant. Cell-free virions 
were pelleted through a 0.5M sucrose exclusion cushion to limit collection of cellular and 
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viral components < 1g/ml density. Sucrose cushion pellets were resuspended and 
subsequently purified by two sequential continuous CsCl self-forming gradients, where 
banded viral particles were harvested at each step by side-tapping with a syringe.  
 
Figure 3.2. Immunofluorescence detection of nsp2 within virally infected cells. A. MARC-145 cell 
monolayers inoculated with VR-2332 at an M.O.I. = 0.1 (48 h.p.i.) were fixed and permeabilized prior to 
detection with the primary antibodies α-nsp2-OTU (1:50), α-nsp2-HV (1:50), α-nsp2-C (1:100), and α-nsp2-C 
(1:50) followed by indirect fluorescence detection with secondary Goat α-Rabbit Alexa Fluor 488 antibody 
(1:25) [Invitrogen, Carlsbad, CA], imaged at 200X-400X magnification. Images were collected using a 
consistent exposure and saturation setting for all images. For each antibody an uninfected cell control (negative) 
is shown, labeled with identical primary and secondary antibody concentrations. B. Selected high magnification 
images of virally infected monolayers. A representative image of α-nsp2-OTU, α-nsp2-HV, α-nsp2-TM, α-
nsp2-C is shown. 
 
Alternatively, virions were initially also purified by semi-discontinuous (10-60%) sucrose 
gradients (Fig. 3.6). As a negative control, uninfected cell cultures of equal surface area and 
media volume were processed by the same methods as viral samples, using the viral bands of 
PRRSV positive isolates as a reference for proper density collection. Collection volumes 
were kept consistent across all samples. The purified viral samples of each PRRSV strain 
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were demonstrated to be infectious, and produced typical CPE on MARC-145 cells, with 
recovery rates of final CsCl purified virus from supernatant at 12-30% by TCID50 
(Spearman-Kärber method) (43, 44) (Table 3.2).  
Table 3.2. Infectivity of viral strains before and after purification 
Viral Strain Total Virus - Supernatant Total Virus - Purified % Recovery 
Lelystad 4.27 x 10
8
 1.26 X 10
8
 30 
VR-2332 9.13 X 10
7
 2.25 X 10
7
 25 
MN184 1.95 X 10
8
 2.25 X 10
7
 12 
rJXwn06 9.13 X 10
7
 2.25 X 10
7
 25 
rSRV07 1.95 X 10
8
 4.00 X 10
7
 20 
    
50% tissue culture infectious dose (TCID50) assay. Low passage MARC-145 cells were either mock infected, 
or inoculated with one of the five strains of PRRSV (VR-2332, rJXwn06, rSRV07, MN184, Lelystad virus) and 
the infection allowed to progress to 60-80% CPE (virally infected) or 2-3d.p.i. (uninfected cell control). At time 
of collection, supernatants were clarified at 5,000 X g (4°C, 1hr) and an aliquot taken for titration prior to 
downstream purification. The initial clarified supernatant as well as the final purified isolates were titered by 
tissue culture infectious dose 50% assay (TCID50) for each strain purified. Initial and final quantities of total 
virus were calculated [TCID50/mL * Volume (mL)] from the supernatant and purified isolates respectively. 
Recovery was defined as the percentage (%) of total virus remaining after purification in relation to the starting 
initial amount (i.e. [Total Virus (Purified) / Total Virus (Supernatant)] * 100]. 
 
Nsp2 associates with highly-purified PRRSV particles by immunoelectron microscopy. To 
determine if nsp2 was associated with the PRRSV particle, purified virus and uninfected 
control samples were assessed by immunoelectron microscopy using antibodies against nsp2. 
Electron micrographs of the purified uninfected cell control were generally free of observable 
contaminants and no vesicles or subcellular structures were noted; however, occasional 
protein aggregates were observed (Fig. 3.4A). Purified viral isolates were found to contain 
pleomorphic, predominantly spherical, virions of regular size (57.9nm ± 8.1nm diameter, 
n=50) consistent with published results (45) (Fig. 3.4B-E). Immunoelectron microscopy 
(IEM) analysis using both α-nsp2-OTU and α-nsp2-HV detected nsp2 associated with 
particles from all purified viral isolates tested, as shown for purified rSRV07 (Fig. 3.4B and 
C) and VR-2332 (Fig. 3.4E). Immunoelectron microscopy was initially conducted with the 
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Lelystad strain; however, the conditions between the α-nsp2 antibodies and ultimately the 
low virion load on the sample grid resulted in a high degree of background which was not 
overcome. Detection of the OTU epitope (Fig. 3.4B and E) was greater than that of the HV  
 
Figure 3.3. A. Nsp2 localizes to high concentration within cell-to-cell protrusions. Nsp2 was confirmed to 
localize to these projections by a variety of α-nsp2 antibodies including α-nsp2-OTU (I and II), α-nsp2-HV (III 
and IV), and α-nsp2-C (V). These projections are observed to span the distance of two or more cell lengths, 
ultimately terminating at either cells which also possess perinuclear nsp2 staining, or in rare cases, within cells 
which appear completely devoid of nsp2 (uninfected) except at the apparent point of cell-to-cell contact (III and 
IV, lower left/center). B. Nucleocapsid co-localizes with nsp2 at the proximal and distal regions of the cell-to-
cell projections. VR-2332 infected MARC-145 cell monolayers dual stained for nsp2 (α-nsp2-OTU) and N (α-
Nucleocapsid, SDow17-A) revealed punctate foci of N along the axis of some nsp2(+) cell-to-cell projections 
(Merge, right cellular projection). However, strongest co-localization occurred at the perinuclear region and, to 
a lesser extent, at the proximal and distal regions of nsp2(+) cell-to-cell projections (Merge).  
 
epitope (Fig. 3.4C), and the transmembrane (TM) and C-terminal (C) epitopes were not 
detectable in the IEM protocol. Detection of virion-associated nsp2 by IEM was not 
consistent across all viral particles (Fig. 3.4B and C), which may be at least partly explained 
by the highly stringent nature of the assay conditions.  
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To further address the possibility that residual unbound nsp2 was being co-purified 
through a nonspecific interaction with the virion surface, viral particles were subjected to an 
elongated purification method where banding times within the cesium chloride purification 
gradients were increased to greater than 48 hours, with the intent to strip residual protein  
 
Figure 3.4. IEM detection of nsp2 on PRRSV virions. Purified virions of PRRSV isolates rSRV07 (HP-
PRRSV), VR-2332 (NA prototype), or the purified product of the uninfected cell control [referred to as purified 
Cell (-)] were labeled by α-nsp2 and imaged by electron microscopy between 32,000X and 150,000X 
magnification. A. Purified Cell (-) labeled with the α-nsp2-OTU (1:100) + secondary Goat α-Rabbit conjugated 
to 1nm CG (1:10) + silver enhancement. B-C.) Purified virions of the HP-PRRSV strain rSRV07 labeled with 
either the α-nsp2-OTU primary (1:100) + Goat α-Rabbit-1nm CG (1:10) + silver enhancement (B) or the α-
nsp2-HV primary (1:100) + Goat α-Rabbit-6nm CG (1:10) (no enhancement) (C). D. Unlabeled VR-2332 
purified virions isolated under the ‘standard’ purification technique. E. Immunodetection of nsp2 (α-nsp2-OTU) 
on VR-2332 purified virions isolated under an elongated purification protocol.  
 
material closely associated to the virions (noted in Fig. 3.4B and C as a dark halo around the 
outside of the virions). Upon centrifugation for this elongated period, a significant fraction of 
the sample was lost due to additional osmotic and mechanical stresses placed on the virion 
during this protracted purification. The resulting virions displayed increased virion diameter 
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and pleomorphism, but had lost the dark halo surrounding the outside of the virion (Fig. 3.4D 
and E). Specific nsp2 staining remained detectable on these extensively purified viral 
particles, indicating that nsp2 is strongly associated with, or most likely incorporated in or 
on, the PRRSV virion (Fig. 3.4E).  
 
Figure 3.5. Western blot detection of nsp2 in cell lysates by custom antibodies. MARC-145 cell lysates of 
VR-2332, rJXwn06, or uninfected negative controls harvested at 48h.p.i. were titrated at 10µg, 20µg, 30µg, and 
40µg (per well) by SDS-PAGE western blot analysis. Full-length nsp2 as well as lower molecular weight 
isoforms were identified with the primary antibodies α-nsp2-OTU (1:2500) (A), α-nsp2-HV (1:2500) (B), and 
α-nsp2-C (1:2500) 
 
Multiple isoforms of nsp2 were present within purified PRRSV particles. To characterize 
the anti-peptide antibodies to nsp2 in western blot assays, increasing amounts (10-40 μg) of 
VR-2332- and rJXwn06-infected, as well as uninfected MARC-145 cell lysates, were 
separated by SDS-PAGE and transferred to nitrocellulose followed by probing with each α-
nsp2 antibody. Consistent with previous observations (38, 46), multiple bands were seen in 
VR-2332- and rJXwn06-infected cell lysates as detected by -nsp2-OTU, -nsp2-HV and -
nsp2-C (Fig. 3.5). The uppermost band (~130 kDa) migrated similarly using all three 
antibodies when compared with the Super Signal ladder (Thermo Scientific) (Fig. 3.5A-C), 
whereas the two bands directly below the uppermost band had a similar migration rate when 
probed with -nsp2-OTU and -nsp2-HV (Fig. 3.5A and B). Lower molecular weight 
74 
 
protein bands were also seen, some of similar migration. As noted in the IFA data, no 
PRRSV specific proteins were recognized by -nsp2-TM (data not shown). Detection of 
rJXwn06 nsp2 proteins exceeded that of VR-2332, most likely due to the fact that rJXwn06 
replicates to 10-100 fold higher titers than VR-2332 in MARC-145 cells (2). 
 
Figure 3.6. Nsp2 packaging is maintained across genetically diverse strains of PRRSV. MARC-145 derived 
viral supernatants of PRRSV isolates of broad genetic heterogeneity including the Lelystad virus (EU 
prototype), VR-2332 (NA prototype), rSRV07 and rJXwn06 (HP-PRRSV), and NA regional MN184 isolate as 
well, as the uninfected control, were individually collected and subjected to virus purification through semi-
discontinuous sucrose gradients as outlined in the materials and methods. Samples were separated by SDS-
PAGE under denaturing/reducing conditions prior to transfer to nitrocellulose and subjected to western blot 
using the α-nsp2-OTU primary antibody followed by detection with the goat α-rabbit HRP secondary. Blots 
were exposed using the chemiluminescence / chemifluorescence ECL+ substrate and imaged by digital capture 
via the Syngene G:Box. 
 
To further investigate nsp2 virion association, western blot analysis was performed 
under denaturing, reducing conditions on purified viruses rJXwn06, VR-2332, rSRV07, 
MN184, and Lelystad, representing diverse genotypes, and gradient purified uninfected cell 
controls (Fig.3.6). Multiple bands of different molecular weights were detected (nsp2 
isoforms) within PRRSV positive samples but not the purified uninfected and gradient 
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banded cell control. Full-length nsp2 proteins of 126 kDa (rSRV07) or 129.6 kDa (VR-2332) 
were expected, as well as additional protein bands that had been observed previously (38, 
46).  
 
 
Figure 3.7. Identification of dominant nsp2 products in purified virions. Highly concentrated purified viral 
samples were generated to identify dominant nsp2 protein products associated with the virion. Two-fold 
dilutions (1:1 - 1:64) of the purified viral isolates rSRV07 and VR-2332, or the purified Cell (-) (only the 
highest concentration of 1:1 is shown) of identical surface area, media volume, purification strategy and 
collection volume, were denatured and reduced prior to electrophoretic separation by SDS-PAGE to 
differentiate minor bands of closely migrating high intensity bands. Black arrows: A consistent core set of nsp2 
products are noted between strains. Black Star: noted repetitive similarly migrating band of differing intensity 
between strains (A and B). Similar banding pattern is noted for the core set of nsp2 isoforms between VR-2332 
as detected by the α-nsp2-OTU (B) and α-nsp2-HV (C) although the ultimate intensities of these bands are 
noted to differ. 
 
Initially, multiple isoforms of nsp2 were detected between 181 and 48 kDa for all 
PRRSV strains examined at low concentrations of virus, consisting of a central set of 
similarly migrating products detected by α-nsp2-OTU, as measured in reference to the 
Benchmark prestained molecular weight marker (Invitrogen, Carlsbad, CA), different from 
the Super Signal Ladder used previously. This initial purification strategy employing a semi-
discontinuous sucrose gradient yielded positive identification of nsp2 within the viral fraction 
(Fig. 3.6). However, the dual rate-zonal and isopycnic centrifugation properties of sucrose 
gradients resulted in diffuse density collection ranges and with it an increased probability of 
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co-collection of non-virion protein contaminants. In order to better assess the relationship of 
nsp2 with the virion, a stringent purification procedure was established by pelleting through a 
sucrose cushion followed by multiple rounds of banding within a continuous cesium chloride 
(CsCl) gradient at high centrifugal forces (Fig. 3.7 and 3.8). Western blot detection of two-
fold  
 
Figure 3.8. Detection of packaged myc-tagged nsp2 isoforms. rV7-Myc expressing a modified c-myc-tagged 
nsp2 was amplified in MARC-145 cells and purified as described in Materials and Methods. Purified virions of 
the nsp2-tagged rV7-Myc, untagged parental VR-2332 virus, or the purified uninfected cell control was assessed 
by western blot using the α-myc mAb 9E10 detection antibody followed by labeling with the secondary goat α-
mouse HRP conjugate and assessed in relation to the Kaleidoscope protein molecular weight marker.  
 
dilutions of CsCl purified rSRV07, VR-2332, and the uninfected cellular control were 
completed to facilitate observation of all bands at optimal intensities and to distinguish 
dominant products for each strain of PRRSV. This more detailed analysis at higher 
concentrations of these two viruses revealed the same central set of nsp2 bands, indicated by 
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the arrows, however different intensities were noted between strains for some of the similarly 
migrating nsp2 isoforms, as shown by the star symbol (Fig. 3.7A and B). Detection of virion 
associated nsp2 products by α-nsp2-HV resulted in a similar banding pattern as noted for by 
α-nsp2-OTU (Fig. 3.7B (OTU), Fig. 3.7C (HV)), however, different intensities of many 
bands were apparent (i.e. 87kDa, 76kDa and 30kDa). It is of note that the total number of 
bands detected were more than previously reported (38). These differences could be partially 
due to the different experimental conditions (direct detection of purified virions versus 
immunoprecipitation of cell lysates) and sensitivity of detection as defined by assay and 
antibodies used. Strain specific bands were also observed; additional products migrating at 
181, 174, 30, 24, and 18 kDa were seen in purified VR-2332 particles that were not present 
in rSRV07 particles (Fig. 3.7). The noted high molecular weight products larger than the 
predicted full-length nsp2 may be the result of post-translational modifications, or incomplete 
replicase polypeptide processing.  
 
Epitope-tagged nsp2 is incorporated into purified PRRSV particles. To further confirm 
nsp2 packaging in PRRSV virions, a recombinant strain of the parental VR-2332 virus 
expressing an exogenous c-myc epitope within the hypervariable region of nsp2 (rV7-Myc), 
was purified by multiple CsCl gradient purification and assessed by western blot in relation 
to the similarly purified products of the uninfected control and the untagged parental VR-
2332. Myc-tagged nsp2 was detected using the primary α-myc 9E10 monoclonal antibody 
(mAb). Multiple myc-tagged nsp2 isoforms were identified to be present within the rV7-Myc 
purified virions but not within the purified uninfected control or the purified virions of the 
untagged parental VR-2332 (Fig. 3.8). The 3X c-myc epitope tag replaced amino acids 323 to 
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431 in relation to the parental VR-2332 virus strain. The net molecular weight change of the 
rV7-Myc nsp2 is therefore expected to be a reduction of approximately 10kDa as compared 
to the wild-type VR-2332 nsp2. A total of eight nsp2-myc isoforms were detected at 119kDa 
(full length nsp2), 82, 71, 66, 55, 53, 51 and 19kDa as measured in reference to the 
Kaleidoscope molecular weight marker (Fig. 3.8). These results further verify, using a 
different antibody, that several isomers of nsp2 were packaged as part of the PRRSV virion.  
 
DISCUSSION 
The rapid evolution of PRRSV has yielded a highly diverse antigenic population of 
PRRSV isolates. A substantial fraction of these mutation and recombination events are noted 
to occur within the coding region of nsp2, the largest and most genetically diverse protein 
encoded by PRRSV. While the nsp2 is encoded by 21-23% of the PRRSV genome, it 
accounts for 23-48 % of the pairwise nucleotide differences between the five wild-type study 
strains presented in this report (Table 3.3, data not shown). Previous research has 
demonstrated that multiple isoforms of nsp2 are generated through viral replication within 
the permissive cell line MARC-145 (38, 46); we have additionally noted the presence of nsp2 
isoforms within virally infected porcine alveolar macrophages (data not shown). Transfection 
of a VR-2332 nsp2-3 construct alone was also shown to be sufficient to yield multiple nsp2 
products (18), a subset of which were of lower molecular mass than the recently reported 
translational isoforms (46). The presence of lower molecular weight nsp2 protein products 
suggests cleavage isoforms may be generated, either by the viral PLP2 protease, cellular 
proteases, or both (18, 38). The role of these isoforms in the viral replication cycle are yet to  
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Table 3.3 Percent pairwise identity between strains 
 
  
 
% pairwise identity with strain:   
Alignment and strain 
     
Whole Genome 
     
(nucleotide) VR-2332 MN184C rJXwn06 rSRV07 Lelystad 
VR-2332 100% 85% 89% 89% 62% 
MN184C 
 
100% 83% 83% 62% 
rJXwn06 
  
100% 99% 61% 
rSRV07 
   
100% 61% 
Lelystad 
    
100% 
      
      Nsp2 (nucleotide) 
   
  
 
VR-2332 MN184C rJXwn06 rSRV07 Lelystad 
VR-2332 100% 73% 83% 82% 52% 
MN184C 
 
100% 71% 71% 56% 
rJXwn06 
  
100% 99% 56% 
rSRV07 
   
100% 55% 
Lelystad 
    
100% 
      
      Nsp2 (protein) 
   
  
 
VR-2332 MN184C rJXwn06 rSRV07 Lelystad 
VR-2332 100% 70% 79% 78% 38% 
MN184C 
 
100% 67% 67% 38% 
rJXwn06 
  
100% 99% 37% 
rSRV07 
   
100% 37% 
Lelystad 
    
100% 
 
Nucleotide (whole genome, nsp2 only) and protein (nsp2) sequence pairwise alignments were generated using 
the Geneious alignment algorithm within the Geneious R6 (v6.1.6, Biomatters Limited) software package for 
each combination of study strains [VR-2332 (U87392), rJXwn06 (EF641008), rSRV07 (JX512910), MN184C 
(EF488739), Lelystad virus (M96262)]. Figures are presented as % homology between whole genomes (top 
panel), nsp2 nucleotide sequence (middle panel), and nsp2 peptide sequence (bottom panel).  
 
be determined, but may facilitate differential localization of nsp2 functional domains within 
the virally infected cell or allow for preferential packaging of selected isoforms.  
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Nsp2 was positively identified upon the outside viral envelope of the virion by IEM 
using antibodies to the viral OTU domain and the HV region, but not by antibodies to the 
predicted TM region or the C-terminal epitope. Failure to detect nsp2 at or downstream of the 
hydrophobic region by IEM might suggest nsp2 was packaged as an integral membrane 
protein, that the native structure precluded detection, or that these antibodies were not well 
suited for the experimental conditions under which IEM was completed. Previous work has 
shown nsp2 and nsp3 proteins of EAV were necessary and sufficient to induce cellular 
membrane rearrangements similar in appearance typically observed during viral infection 
(23). PRRSV nsp2 possesses a hydrophobic domain downstream of the HV region that is 
predicted to function in cellular membrane rearrangement similar to EAV nsp2. It is therefore 
predicted that PRRSV nsp2 protein associates with the virion during packaging through 
integration with the membrane of the viral envelope, however further studies are needed to 
define the relationship of nsp2 with the virion.  
Purified virions possessed multiple isoforms of nsp2, whereas packaged isoforms 
were similar in size to a subset of the isoforms detected within virally infected cell lysates. 
Highly concentrated purified isolates were additionally found to possess a core set of nsp2 
isoforms, as well as strain specific isoforms. While it was unlikely that the α-nsp2 custom 
antibody set was cross-reacting with an enriched cellular product co-purifying with the virion 
density fraction (and not identified in the uninfected cellular control), to eliminate this 
possibility we verified nsp2 packaging using a recombinant VR-2332 strain expressing a c-
myc tagged nsp2 (rV7-Myc), which further confirmed our initial results (Fig. 3.8). Reduced 
growth kinetics for rV7-Myc hindered generation of purified viral stocks to as high of a 
concentration as wild-type viruses, particularly VR-2332 and the HP-PRRSV isolates 
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rJXwn06 and rSRV07. Due to the lower initial viral titers, it is possible minor nsp2 isoforms 
were not identified with this virus.  
The function(s) and exact boundaries of nsp2 isoforms are yet to be determined, 
however, it was generally noted that IFA detection of nsp2 by three (OTU, HV, C) of the 
four target epitopes did maintain subtle differences in cellular localization (Fig. 3.2). Nsp2 
predominantly localized to the perinuclear region of infected cells (VR-2332, 48 h.p.i) 
similar to what has been previously described for PRRSV (47) and EAV (48) when assessed 
by IFA (Fig. 3.2A-B). The noted differences in nsp2 localization as detected by targeting the 
N-terminal protease domain, the central HV region, or the C-terminal domain was generally 
subtle, but was consistent across a range of replicates and antibody dilutions (Fig. 3.2B). It is 
postulated that some isoforms, such as those possessing the recognized hydrophobic region, 
may maintain a constrained localization in and around internal membrane structures while 
isoforms lacking this domain may adopt a more diffuse localization pattern. It is currently 
unknown if nsp2 isoforms localize preferentially to different regions of the cell but would 
allow spatial separation of nsp2 functional domains as a mechanism of targeted activity.  
Interestingly, nsp2 was observed to also localize to cellular projections that appeared 
to connect two or more cells over distances of multiple cell lengths, consistent between the 
three target epitopes (OTU, HV, C-terminal) (Fig. 3.3). Cellular projections were noted to 
occur in equal frequency in infected and uninfected cells and therefore not believed to be 
virally derived or nsp2 derived, however, nsp2 densely localized to these protrusions. In 
some occurrences the cell-to-cell process, extending from an infected cell to uninfected cell, 
resulted in a high intensity point of nsp2 staining at the apparent point of contact with 
membrane/cytosol of the uninfected cell (Fig. 3.2A, panel IV lower center). Previous work 
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by Cafruny et al. indicated a cell-to-cell transmission route occurs for PRRSV within 
MARC-145 cells during mid-phase viral growth cycle (>24 hours post infection) (49), as 
measured by α-N IFA detection of M.O.I. independent viral foci development. Similarly, in 
this study, N protein was found to weakly co-localize with nsp2 at distal and proximal 
regions of nsp2 (+) cellular projections (Fig. 3.3B, Merge) and with a punctate pattern along 
the axis of some projections (Fig. 3.3B, right projection).  
Investigations into the role of nsp2 in viral replication and immune evasion have 
yielded an increasingly complex understanding of nsp2 mechanisms. This has been further 
compounded by the recent descriptions of translational (46) and cleavage (38) nsp2 isoforms 
of yet unknown function. Nsp2 is a region of substantial diversity at both the genetic and 
protein levels whereas emerging strains often possess novel mutations, insertions and 
deletions within this coding region (12, 30, 50). Nsp2 is the most genetically diverse protein 
of PRRSV; however, the mechanism potentiating the higher mutation rate within the nsp2 
coding region has not been defined. Curiously, nsp2 elicits a strong humoral immune 
response in animals experimentally infected with PRRSV, and the magnitude of that 
antibody responses is similar to those generated against the highly immunogenic and highly 
abundant N protein by 14 days post infection (27). N protein is a dominant component of the 
PRRSV virion (20-40% of the total virion protein mass) (28, 51), so it was therefore 
surprising that the nsp2 replicase protein with no known extracellular localization or function 
could elicit an antibody response commensurate to that generated against the N protein. 
Likewise, it has been shown that hosts infected or vaccinated with the arterivirus prototype 
virus EAV established a serological response to nsp2 (52), suggesting that the mechanism by 
which the anti-nsp2 humoral immune response is elicited may be conserved across the 
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Arteriviridae. Genetic alignment of the nsp2 coding region of PRRSV demonstrates a large 
central bipartite region of high genetic variability (Fig. 3.1, unpublished results), which 
includes a number of single nucleotide polymorphisms (SNPs), insertions, and deletions 
between strains (12, 53, 54). Much of this central hypervariable region was found to be 
nonessential for the North American Type 2 prototype strain VR-2332 to replicate within the 
MARC-145 cell line (37). Replication of a viral mutant possessing a large deletion within the 
hypervariable region of nsp2 (Δ324-726aa) was also found to be replication competent in 
vivo, yet with reduced kinetics relative to wild type virus or other mutants with smaller nsp2 
hypervariable deletions (Δ727-813aa, Δ543-726aa and Δ324-523aa) (55) . The major 
factor(s) potentiating the high evolutionary rate of nsp2 is currently unknown, however 
multiple experiments have delineated T-cell and B-cell epitopes within the nsp2 coding 
region either bioinformatically or experimentally (17, 21, 29, 30, 56). Inclusion of nsp2 
within the PRRSV virion suggests it may function in previously unknown roles related to 
extracellular function, entry, or immediate-early viral replication events. The known robust 
humoral immune response generated against nsp2, coupled with the observed high genetic 
diversity within this coding region, points towards a driving selective pressure against the 
nsp2 protein acting to alter or hinder one or more requisite functions. Nsp2 packaging was 
conserved across a genetically diverse set of study strains ranging from original outbreak 
isolates to contemporary highly pathogenic strains, suggesting this is a wholly conserved 
feature of PRRSV. These packaged nsp2 isoforms shared a consistent 'core' set between viral 
strains, however, additional strain specific products were also identified. These findings 
suggest the ultimate antigenic composition of the virion may be more complex than 
originally predicted. Identification of PRRSV nsp2 packaging establishes a foundation for 
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new considerations relevant to future vaccine design, and has important implications on yet 
unexplored functions of nsp2 as a structural protein.  
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ABSTRACT 
 Membrane modification of host subcellular compartments is critical to the replication 
of many RNA viruses. Enveloped viruses additionally require the ability to requisition 
cellular membranes during egress for the development of infectious progeny. Porcine 
reproductive and respiratory syndrome virus (PRRSV) is an enveloped virus encoded by a 
positive-sense single-stranded RNA genome. PRRSV nsp2 is a predicted transmembrane 
protein with a recognized C-terminal hydrophobic region; however, the functionality of the 
putative nsp2 transmembrane domain has not been defined. In this report, the insertion and 
topology of nsp2 was assessed using cell free translation in the presence or absence of 
membranes. Full-length nsp2 was found to strongly associate with membranes and, 
surprisingly, two additional large nsp2 isoforms of approximately 117 and 106 kDa were 
enriched within the membrane fraction. Membrane integration was further defined for full-
length nsp2 through high-speed density fractionation, protection from protease digestion, and 
immunoprecipitation. The results demonstrated that nsp2 integrated into the membranes with 
an unexpected topology, where the N-terminal (cytoplasmic) and C-terminal (luminal) 
domains were orientated on opposite sides of the membrane surface.  
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INTRODUCTION 
Viruses are obligate intracellular pathogens that modulate the host cellular environment to 
establish locations conducive to the biogenesis of infectious progeny. To date, all positive-
sense RNA viruses that have been studied modify host cellular membranes of intracellular 
compartments, including mitochondria (1, 2), chloroplasts (3), endoplasmic reticulum 
(ER)/Golgi (3-6), and endosomes/lysosomes (7) to establish structured sites of replication 
(replication complexes (RCs)). Enveloped viruses further require the ability to capture 
cellular membranes as a component of progeny virions during egress. Porcine reproductive 
and respiratory syndrome virus (PRRSV) is an enveloped single-stranded positive-sense 
RNA virus within the Arteriviridae family (8). The first approximately three-fourths of the 
genome encode at least 14 nonstructural proteins (nsp) from a large polyprotein precursor 
(pp1a/b) which is co-translationally and post-translationally processed by four viral proteases 
including the papain-like cysteine proteinase 1α (PLP1α; nsp1α), PLP1β (nsp1β), PLP2 
(nsp2), and the main serine proteinase (SP; nsp4) (Fig. 4.1) (9). The final one-fourth of the 
genome encodes nine additional ORFs, including all canonical structural proteins (10). Of the 
replicase proteins, nsp2 is unique due to its large size (~1196 amino acids (aa)), genetic 
heterogeneity, its participation in diverse roles supporting the viral replication cycle, and its 
packaging within the PRRSV virion (11-16). Nsp2 is the largest protein encoded within the 
PRRSV genome and is also the location of the greatest level of genetic heterogeneity 
identified between strains (17). The N-terminal PLP2 protease domain of nsp2 is recognized 
for its dual functionality between viral pp1a/b processing (9, 18) and its immunomodulatory 
deubiquitinating activity (19-21). However, outside of the context of the PLP2 protease 
domain, very little is known about the potential functional roles for the large central and C- 
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Figure 4.1. PRRSV ORF1a encodes putative multi-spanning transmembrane domains. Predicted 
hydrophobicity of the entire ORF1a coding region is depicted using the TMHMM prediction algorithm within 
the Geneious software platform. A) Top: graphical representation of pp1a noting the location of viral protease 
domains PLP1α, PLP1β, PLP2, and SP. Middle: model of membrane integration sites and topologies of pp1a 
based upon predicted transmembrane spanning helices. Regions where the putative transmembrane spanning 
domains are unclear are denoted in white. Bottom: plot of hydrophobicity strength scores (TOPCONS) and 
amino acid charge by position. B) Possible topologies of nsp2 dependent on even (1 and 2) or odd (3 and 4) 
number of transmembrane spanning elements and cytoplasmic versus luminal orientation.  
 
terminal domains of nsp2. The PRRSV nsp2 is a predicted transmembrane protein due to the 
recognized hydrophobic C-terminal domain (Fig. 4.1). The arterivirus prototype equine 
arteritis virus (EAV) nsp2 has been shown to function in membrane rearrangement in support 
of the formation of double-membrane vesicles (DMVs) RCs (22, 23) and ORF1a polyprotein 
processing (18, 24, 25), believed to be intrinsically associated with ER membrane integration 
(26). Recently the PRRSV nsp2 was also shown to be packaged within or upon the PRRSV 
virion, presumably through interaction with the viral envelope (16). While PRRSV nsp2 has 
been historically recognized as a putative multi-spanning transmembrane protein, the 
membrane insertion, topology and functionality of the nsp2 hydrophobic domain has never 
been conclusively determined. In this report, membrane association of the full-length nsp2 
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and sub-dominant isoforms are identified and further nsp2 is demonstrated to be an integral 
membrane protein with an unexpected topological orientation within the cell-free in vitro 
translation system.  
 
RESULTS 
Nsp2 expression. Nsp2 was assessed in the absence of all other viral components by use of a 
cell-free translation system. Translation of the non-template control (NTC) or pcDNA vector 
(vector control) were free of any detectable translation products (Fig. 4.2A-D), however, 
general 
35
S-cysteine cross-labeling of microsomal membrane components was noted (Fig. 
4.2B and D). Isotopically labeled nsp2 translation products were shown to be predominantly 
full-length nsp2 of an approximate molecular mass of 130kDa (Fig. 4.2A), consistent with 
the expected product size of 129.4kDa. Additional secondary translation products of lower 
molecular weight were also faintly visible under normal exposure conditions (Fig. 4.2A, 
black arrows) and could be easily visualized when overexposed (Fig. 4.2C). The expression 
of either untagged (pNsp2), N-FLAG (pNsp2 N-FLAG), or C-FLAG-tagged (pNsp2 C-
FLAG) nsp2 constructs resulted in the generation of full-length nsp2 protein products of 
comparable molecular weight (Fig. 4.2A), however, there were noted differences in the 
banding pattern of some of the lower molecular weight translation products of pNsp2 N-
FLAG as assessed in relation to the C-FLAG-Tagged expression construct (Fig. 4.2C, lanes 4 
and 5). Multiple products between 50-75 kDa of the N-FLAG construct displayed a minor 
upward band-shift as compared to the C-FLAG or the untagged nsp2 expression construct 
(Fig. 4.2A and C; black arrows). The lower molecular weight products of the C-FLAG and 
untagged nsp2 expression constructs appeared to have similar migration patterns. Temporal  
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Figure 4.2. Cell-free translation of PRRSV nsp2. VR-2332 nsp2 coding region was isotopically labeled by 
transcription/translation coupled reaction in rabbit reticulocyte lysate with [35] S-cysteine either without (A and 
C) or with (B and D) microsomal membranes. [35]S-labeled translation products were loaded at 100,000 
counts/lane and PAGE separated under denaturing, reducing conditions in MES running buffer. C) 
Overexposed image of (A) to highlight the low molecular weight products; D) overexposed image of (B) to 
highlight microsomal cross-labeling and low molecular weight products. 1 = Non-template control (NTC), 2 = 
pcDNA vector control, 3 = pVR-nsp2, 4 = pVR-nsp2 5’FLAG, 5 = pVR-nsp2 3’FLAG.  
 
studies showed that the lower molecular weight products emerged early during the translation 
reaction, as early as 15 minutes and at times preceding the detectable generation of full-
length product (data not shown). There was also the appearance of a minor secondary 
product that migrated at a larger molecular mass (~149kDa) than the complete nsp2 product. 
This large 150kDa protein was an observed product for all nsp2 expression constructs from 
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both closed (circular) (Fig. 4.2-6) and linearized templates (data not shown). A 150kDa band 
with a similar migration pattern was also a noted nsp2 product within purified virions via 
detection by multiple anti-nsp2 antibodies (in contrast to 
35
S-cysteine labeling) (16). This 
high molecular weight product was more apparent when nsp2 was expressed with canine 
microsomal membranes (microsomes) (Fig. 4.2B). Addition of microsomes to translation 
reactions confounded the visualization of the lower molecular weight products, partly due to 
35
S cross-labeling of microsomal components (Fig. 4.2B and D, lanes 1 and 2).  
 
Nsp2 isoforms differ in PAGE gel banding pattern. Nsp2 translation products were 
assessed by α-FLAG immunoprecipitation (IP) to define the generation of N-terminal and C-
terminal nsp2 isoforms in relation to the full-length product (Fig. 4.3). As expected untagged 
nsp2 expression products were not immunoprecipitated (Fig. 4.3 A and B; lane 3). IP of 
FLAG-tagged nsp2 constructs clearly demonstrated differences in generation of N-terminal 
and C-terminal isoform generation in the absence of microsomes (Fig. 4.3A). Numerous N-
terminal FLAG-tagged nsp2 products efficiently precipitated at a range between 150kDa and 
5kDa (Fig. 4.3 lane 4). In contrast, only two low molecular weight C-terminal nsp2 isoforms 
were efficiently precipitated by α-FLAG IP in the absence of membranes (Fig. 4.3A lane 5). 
In addition to the full-length nsp2 and the 150 kDa nsp2 protein product, C-terminal isoforms 
of approximately 73 and 68kDa were observed (Fig. 4.3A lane 5). These noted differences 
between N- and C-FLAG constructs were diminished when translated in the presence of 
microsomes (Fig. 4.3B, lanes 4 and 5). Translations in the presence of microsomes resulted 
in full-length nsp2 as the dominant product. The appearance of secondary products was  
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Figure 4.3. N-terminal and C-terminal nsp2 isoforms. Translation products generated from reticulocyte 
lysate expression of nsp2 constructs were immunoprecipitated targeting the FLAG epitope. IP products were 
PAGE separated under reducing/denaturing conditions. Expression was completed either without (A) or with 
(B) microsomal membranes. 1 = Non-template control (NTC), 2 = pcDNA vector control, 3 = pNsp2, 4 = 
pNsp2 5’FLAG, 5 = pNsp2 3’FLAG.  
 
significantly reduced when nsp2 constructs were expressed in the presence of microsomal 
membranes (Fig. 4.3B). A number of faint low molecular products were still observed within 
the N-FLAG+microsomes IP (Fig. 4.3B, Lane 4) but were of lower intensity. C-terminal 
isoforms (C-FLAG+microsomes) comprised only a small fraction of translation reaction 
products and were only visualized under extreme overexposure conditions, but were able to 
be visualized (data not shown). IP reactions of nsp2 translation products demonstrate 
differential banding patterns of N-terminal and C-terminal low-molecular weight isoforms 
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(Fig.3A). Further, the addition of membrane to the reactions was shown to apparently 
stabilize the translation reaction yielding predominantly full-length nsp2.  
 
Nsp2 and select isoforms strongly associate with membranes. The membrane association 
of nps2 was assessed by isolating the membrane fraction of translation reactions through 
high-speed centrifugation. Equal counts of the initial translation reactions of both nsp2 (- 
microsomes) and nsp2 (+ microsomes) were assessed by PAGE (Fig. 4.4A). As noted 
previously, multiple subdominant low molecular weight products were noted when nsp2 was 
expressed in the absence of membranes (Fig. 4.4A, - microsomes). While equal counts of 
both translation reactions (with and without microsomes) were added, the noted 
35
S-cysteine 
cross-labeling of microsomal components resulted in a weaker intensity of full-length nsp2 
(per 100,000 counts; Fig. 4.4A, + microsomes). To assess the relative pelleting efficiencies of 
35
S-cysteine labeled nsp2 either without microsomes (Fig. 4.4B; - microsomes) or with 
microsomes (Fig. 4.4B; + microsomes); equal counts of each translation reaction was 
pelleted by high-speed ultracentrifugation in isotonic buffer as outline in the materials and 
methods. As expected, in the absence of membranes 
35
S-cysteine labeled nsp2 failed to pellet 
under the experimental conditions outline, demonstrating free nsp2 is not pelleted as part of 
the isolated membrane fraction (Fig. 4.4B; - microsomes). Extending the centrifugation time 
four-fold from 30min to 120min did not result in isolation of free nsp2 in the membrane 
fraction (Fig. 4.4B; - microsomes). In contrast, 
35
S-cysteine labeled full-length nsp2 was 
efficiently isolated within the membrane fraction of translation products which were 
expressed in the presence of microsomal membranes (Fig. 4.4B; + microsomes). Increasing  
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Figure 4.4. Nsp2 associates strongly with membranes. [35]S-labeled pNsp2 translation products were 
expressed either with (+) or without (-) the addition of microsomal membranes. A) Translation products at 
100,000 counts per lane. B) Translation products equal to 100,000 counts/reaction were pelleted to enrich for 
the microsomal fraction. Eluted pellets were assessed by PAGE separation under reducing, denaturing 
conditions.  
 
the spin times by four-fold did not result in any significant increase in isolated product (Fig. 
4.4B; + microsomes). The results show full-length nsp2 is strongly membrane associated.  
 Surprisingly, a second lower molecular weight product in addition to full-length nsp2 
was observed to strongly associate with membranes (Fig. 4.4; + microsomes). While low 
molecular weight isoforms were only faintly visible within the original translation reaction 
under the exposer conditions depicted (Fig. 4.4A, + microsomes); the secondary lower 
molecular weight band was of equal intensity to the full-length product in the membrane 
fraction (Fig. 4.4B, + microsomes) demonstrating an enrichment of this product within the 
microsomal fraction. A repeat of this experiment allowed a more detailed resolution of the 
nsp2 expression products (-/+ microsomes) and subsequent isolation of the membrane 
fraction was repeated (Fig. 4.5). Generation of full-length nsp2 and secondary lower 
molecular weight products were similar in banding pattern between expression without 
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microsomes (Fig. 4.5A lane 1) and with microsomes (Fig. 4.5A lane 2). Significant cross-
labeling of microsomal components were noted between 15-5kDa (Fig. 4.5A lane 2). 
Isolation of the membrane fraction again showed the efficient isolation of membrane 
associated nsp2 but not free nsp2 (Fig. 4.5B). Additionally, lower molecular weight nsp2 
isoforms of approximately 117 and 106kDa (Fig. 4.5A, black arrows) co-purified in the 
membrane fraction (Fig. 4.5B, black arrows). All other nsp2 isoforms were not found to be 
associated with the membrane fraction; demonstrating selective purification of only a 
fraction of the nsp2 isoforms (Fig. 4.5B, black arrows). Further, the 117 and 106kDa 
isoforms were noted to be enriched within the membrane fraction as co-dominant products 
(Fig. 4.5B). These membrane isolation studies show the selective enrichment of nsp2 
including the full-length nsp2 and two additional nsp2 isoforms.  
 
Nsp2 is an integral membrane protein. To assess whether the introduction of the FLAG-
tag epitope to either the N- or C-terminus of nsp2 altered the ability of nsp2 to associate with 
membranes, the membrane fraction of N-FLAG and C-FLAG nsp2 expression products were 
assessed in relation to the untagged nsp2 (pNsp2) (Fig. 4.6). As noted previously, the 
expression of the pcDNA vector only, or the NTC, did not result in the generation of any 
detectable protein product and subsequently no 
35
S-cysteine labeled product was observed in 
the microsomal fraction either without or with microsomal membranes (Fig. 4.6 lanes 1 & 2; 
left and right panels respectively). As expected, when microsomes were not added to the 
translation reaction N-FLAG and C-FLAG products did not precipitate with the membrane 
fraction (Fig. 4.6; - microsomes lanes 4-5). Expression of N-FLAG and C-FLAG nsp2 
constructs in the presence of microsomal membranes resulted in the efficient isolation of  
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Figure 4.5. Membrane enrichment of select nsp2 isoforms. pVR-nsp2 [35] S-labeled translation products 
were expressed either with or without canine microsomal membranes. Lane 1 = (-) microsomes, Lane 2 = (+) 
microsomes. A) Translation reactions PAGE separated under reducing, denaturing conditions. B) Translation 
products equal to 100,000 counts/reaction were pelleted at 150,000 x g for 1hr to enrich for the microsomal 
fraction. Eluted pellets were assessed by PAGE separation under reducing, denaturing conditions. Black arrows 
indicate the approximate molecular weight of enriched nsp2 sub-dominant products. 
 
nsp2 within the microsomal fraction, similar to that of the untagged nsp2 (Fig. 4.6; + 
microsomes). These results show that the insertion of the FLAG epitope to the N-terminal or 
C-terminal coding regions of nsp2 does not affect membrane association of nsp2.  
 Protein domains that have either embedded within the membrane or that have 
traversed the bilayer and are enclosed within the luminal surface of the microsomes are 
protected from protease digestion (27). To test whether nsp2 functions as an integral 
membrane protein, the isolated membrane fraction of each translation product was subjected 
to proteinase K digestion [protease protection assays (PPA)]. Proteinase K PPA products 
were assessed by PAGE to define any 
35
S-cysteine labeled product protected from digestion  
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Figure 4.6. Membrane Enrichment of FLAG-tagged products. [35]S-labeled translation products were 
expressed either with or without canine microsomal membranes. Products were pelleted at 150,000 x g (4C) 
1hr. Eluted pellets were subjected to PAGE separation under reducing, denaturing conditions. 1 = Non-template 
control (NTC), 2 = pcDNA vector control, 3 = pVR-nsp2, 4 = pVR-nsp2 5’FLAG, 5 = pVR-nsp2 3’FLAG.  
 
(Fig. 4.7). A single 13-15kDa protein product from the PPAs was observed to be protected 
from digestion (Fig. 4.7) whereas N-FLAG, C-FLAG, and untagged nsp2 membrane 
associated products were equally protected (Fig. 4.7, lanes 3-5). The observed 15kDa 
protected product is similar in size to both the predicted multi-pass transmembrane domain 
(TM1-5; 17kDa) and the C-terminal domain downstream of the TM region (20kDa). These  
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Figure 4.7. Nsp2 fragment is protected from protease degradation by membrane insertion. [35]S-labeled 
translation products were expressed either with or without canine microsomal membranes. Products were 
pelleted at 150,000 x g (4C) 1hr. Membrane associated nsp2 was subjected to protease protection assay 
(proteinase K digestion) as outlines in the materials and methods and assessed by PAGE separation under 
reducing, denaturing conditions. 1 = Non-template control (NTC), 2 = pcDNA vector control, 3 = pVR-nsp2, 4 
= pVR-nsp2 5’FLAG, 5 = pVR-nsp2 3’FLAG.  
 
results demonstrate nsp2 integrates within microsomal membranes and that an approximately 
15kDa product is protected from digestion either through integration within the membrane 
bilayer (transmembrane helices) or through orientation within the luminal surface of the 
microsomal compartment.  
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Figure 4.8. The C-terminus of nsp2 is protected from protease degradation by membranes. A) Translation 
products were expressed in the presence of microsomes. [35]S-labeled translation products were stabilized in 
TBSS and an enriched microsomal fraction was generated through pelleting at 150,000xg 1hr. The pelleted 
fraction was digested with proteinase K (protease protection assay) and further processed by 
immunoprecipitation, targeting the exogenous FLAG epitope (α-FLAG). 1 = Non-template control (NTC), 2 = 
pcDNA vector control, 3 = pVR-nsp2, 4 = pVR-nsp2 5’FLAG, 5 = pVR-nsp2 3’FLAG. B) Graphical 
representation of the predicted membrane associated functions of the weakly hydrophobic putative 
transmembrane domains TM1 and TM3. 
 
Nsp2 membrane integration yields an unexpected topology. PPA experiments 
demonstrated a ~15kDa protein product was protected from proteinase K digestion, defining 
nsp2 insertion into microsomal membranes. To further define the topology of nsp2, and to 
identify the protected domain of nsp2, PPA products were subjected to IP analysis (Fig. 
4.8A). IP analysis of PPA protected fragments clearly demonstrated the 15kDa fragment to 
originate from the C-terminal domain (Fig. 4.8A). The protected fragment from the PPA of 
both the untagged nsp2 and N-FLAG nsp2 constructs did not precipitate by IP pull-down 
(Fig. 4.8A; lanes 3 and 4). While a single ~15kDa band was observed from the PPA reaction  
104 
 
 
Figure 4.9. RFS alters the hydrophobicity profile of nsp2. Predicted hydrophobicity profiles using the 
TMHMM algorithm depicted for both the full-length nsp2 (VR-2332) and nsp2-TF (-2 RFS). Red arrows 
denote the putative transmembrane helices as defined by the TOPCONS prediction algorithm. Green lines 
define the predicted probability of an encoded transmembrane domain (TMHMM) from 0% (bottom) to 100% 
(top). Images were generated using the Geneious software platform.  
 
(Fig. 4.7), two C-terminal FLAG tagged nsp2 product of approximately 15kDa and 5kDa 
were identified in the IP pull-down of PPA reactions. It is unknown if the 5kDa protein was 
enriched within the IP reaction or if it is a partially digested product. Partially digested 
products could result from low amounts of incompletely inactivated proteinase K incubated 
for long time points (≥18hr) during the IP reaction. These results clearly demonstrate the C-
terminal domain of nsp2 adopts a luminal topology. Further, the large hydrophilic N-terminal 
domain (PLP2 & HV; ~90kDa) was not observed to be protected from digestion, indicating a 
cytoplasmic orientation. These results define an unexpected topology of nsp2 where the large 
N-terminal domain is maintained on the cytoplasmic surface and the C-proximal 
hydrophobic region integrates within the membrane orientating the C-terminal domain within 
the luminal surface.  
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DISCUSSION AND CONCLUSION 
Within ORF1a, three proteins possess recognized hydrophobic domains: nsp2, nsp3 
and nsp5 (Fig. 4.1). Of the three, nsp2 is unique in that the hydrophobic domain comprises 
only a small fraction of the protein coding sequence. The arterivirus nsp2 is a large multi-
functional protein that has been reported to interact with a diverse set of viral and cellular 
proteins, and cellular membranes (21, 22, 24, 28, 29). RNA viruses modify host cellular 
membranes of intracellular compartments to establish structured sites of replication including 
mitochondria (1, 2), chloroplasts (3), ER/Golgi (3-6), and endosomes/lysosomes (7); creating 
factories for the biogenesis of genomic and protein constituents of progeny virions (30, 31). 
The arterivirus nsp2 is believed to participate in cellular membrane reorganization of the 
endoplasmic reticulum (ER) leading to the formation of characteristic double-membrane 
vesicle (DMV) RCs (22), and to be packaged within the PRRSV virion presumably by 
association within the viral envelope (16). The biological aspects of PRRSV nsp2 membrane 
integration have not been defined and it is unknown what functional role the recently 
identified translational (13) and cleavage (32) isoforms play in support of virion replication 
cycle. To address these questions we sought to define nsp2 transmembrane insertion. Since 
strong viral protein-protein interactions can complicate assessment of native transmembrane 
insertion (29), and additionally PRRSV nsp2 interacts with a wide range of cellular proteins 
(28), we chose to complete these initial studies on nsp2 transmembrane functionality within a 
reductionist cell-free translation system in the absence of all other viral proteins.  
Fig. 4.1A proposes a simple diagram of PRRSV replicase integral membrane proteins 
as outlined by the predicted hydrophobicity strength scores (TMHMM) of the entire ORF1a  
 
106 
 
Table 4.1. Prediction of nsp2 transmembrane helices 
 
Nsp2 (VR-2332 (DQ217415)) transmembrane domains were assessed by bioinformatic predictive algorithms 
Phobius (33); HMMTOP 2.0 (34); SCAMPI (35); TOPCONS (36); OCTOPUS (37); PRO/PRODIV-TMHMM 
(38); and MemBrain [TMH prediction; (39)] using default settings unless otherwise noted in the materials and 
methods. On average, most prediction algorithms define four transmembrane spanning domains (TM1-4); 
however, the aggregated output from the nine predictive programs defines a total of five transmembrane 
spanning helices (Region 1-5).  
 
polyprotein. The transmembrane prediction of the ORF1a hydrophobic domains (Fig. 4.1A; 
green line) depicts multiple regions where the number TM helices are inconclusive. Of the 
three putative ORF1a transmembrane proteins, nsp2 transmembrane prediction is the most 
unclear. Further, discrepancies were noted when assessing the putative nsp2 transmembrane 
domain by nine separate bioinformatic predictive algorithms (Table 4.1). The ultimate 
number of functional transmembrane domains encoded and the resulting topological 
orientation (in/out) (Fig. 4.1B, 1-4) has important implications on the mechanism of 
ORF1a/b polyprotein processing, orientation of downstream ORF1a putative transmembrane 
proteins, and on potential function(s) of nsp2 within the viral reticulovasicular network 
(RVN) (26). Because of these unknowns we sought to define the functionality of the putative 
transmembrane domain and further define the topological orientation of nsp2.  
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In this report we demonstrated the membrane association of both nsp2 and select 
isoforms, and further defined a surprising topological orientation for nsp2. Expression of 
nsp2 within reticulocyte lysate resulted in multiple sub-dominant protein products in addition 
to the full-length nsp2, similar to the banding pattern previously described (16) including a 
faint triplicate between 80kDa - 60kDa and a tight duplet/triplicate at or near the 50kDa 
range (Fig. 4.2). IP pull-down of FLAG-tagged nsp2 constructs further identified the lower 
molecular weight products as isoforms of nsp2 (Fig. 4.3). Clear differences in banding 
patterns between N-terminal (N- FLAG) and C-terminal (C-FLAG) isoforms emerged from 
IP reactions (Fig. 4.3), predicted to be at least in part due to differential products derived 
from nsp2 cleavage (32). An alternative hypothesis that the lower molecular weight bands are 
abortive translation products is also possible in some instances. Translation within the cell-
free system (reticulocyte) of such a large protein is near the upper range for this assay and 
could help explain some of the minor secondary N-terminal isoforms (N- FLAG). Abortive 
translation products however would not explain the clearly defined low molecular weight C-
terminal nsp2 isoforms possessing the C-FLAG epitope observed within α-FLAG IP 
reactions. It is probable that the defined bands between 50kDa – 75kDa (Fig. 4.3) were 
generated through cleavage of the nsp2 protein by an as yet undefined mechanism. Initial 
attempts were made to express nsp2 within the reticulocyte system in the presence of 
multiple protease inhibitors, all of which completely aborted translation (data not shown). 
Addition of microsomes to the translation reaction clearly stabilized nsp2 expression, 
potentiating generation of predominantly full-length nsp2 product (Fig. 4.3B). Isolation of 
the membrane (microsomal) fraction demonstrated the strong association of not only the full-
length nsp2 protein (Fig. 4.4) but additionally the enrichment of two nsp2 isoforms migrating 
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at approximately 117kDa and 106kDa (Fig. 4.5). These results remained consistent with the 
isolation of membrane bound FLAG-tagged nsp2 constructs (Fig. 4.6). The isolation of two 
tightly membrane associated nsp2 isoforms was surprising since enrichment in banding 
intensity (from sub-dominant translation products to dominant products within the membrane 
fraction) suggest a tighter interaction with the membrane compared to the full-length product. 
Further, these isoforms are consistent in size to the previously reported translational isoforms 
nsp2TF and nsp2N generated through -2 RFS and -1 RFS, respectively (13). While the 
critical requirement of nsp1β for efficient RFS within transmembrane region 1 (TM1) of 
nsp2 was recently demonstrated (15), strongly suggesting these are not translational 
isoforms, it is important to note that the -2 RFS dramatically changes the predicted 
hydrophobicity of the multi-spanning transmembrane region strongly favoring membrane 
insertion (strong hydrophobicity profiles; Fig. 4.9).  
Nsp2 membrane integration was conclusively determined and the topology defined 
through investigations utilizing protease protection assays (PPA) against proteinase K 
digestion (Fig. 4.7). Results demonstrated a small fragment was protected from digestion, 
defining membrane insertion, and IP further confirmed the protected fragment (15 kDa) was 
derived from the C-terminus (Fig. 4.8A). The integration of nsp2 with a topological 
orientation yielding N- and C-termini on opposing sides of the membrane is counterintuitive 
since the established polyprotein processing cascade requires the PLP2 (OTU) protease 
domain and the nsp2-3 junction site is contiguous and not impeded by physical barriers. 
However, the historical rules of membrane integration and ‘positive-inside’ topology (40) has 
been muddled by recent unexpected findings from the growing number of solved high-
resolution structures of integral membrane proteins and correlative biological data (41). 
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Observed topological variations include dual-topology proteins (“flip-flopping” or 
“indecisive” integration) (42), mixed or diverse topological profiles of monotopic (43) and 
polytopic membrane proteins (44, 45) (topological heterogeneity), and temporally dynamic 
topologies which either re-orient post- translationally (46) or, as in the case of the hepatitis B 
large envelope glycoprotein (L), a fraction (~50%) re-orients in a protracted Hsc70/Bip 
chaperone-mediated process (47) (dynamic topologies). Topological variation has, at least in 
part, been attributed to inefficiencies in integration of weakly hydrophobic domains (48, 49). 
As noted in Fig. 4.1, nsp2 encodes three regions of strong hydrophobicity (VR-2332 nsp2 
874-902aa, 960-980aa, and 986-1007aa) and two weaker hydrophobic domains (nsp2 845-
864aa and 906-927aa) (Fig. 4.1). Further assessment of the nsp2 hydrophobic region by the 
use of multiple bioinformatic predictive programs showed that while most algorithms define 
a succinct set of four potential transmembrane domains (Table 4.1; TM1-4), the aggregated 
output of the nine separate bioinformatic transmembrane/hydrophobicity predictive 
algorithms describe a total of five distinct putative transmembrane helices within PRRSV 
nsp2 (Table 4.1; Region 1-5).  Originally we postulated that one of the two weak 
hydrophobic domains would not be functional (Fig. 4.1B, 1 and 2) in order to maintain an 
even number of transmembrane domains, allowing for the cis-cleavage of the nsp2-3 junction 
following co-translational integration within the membrane. However, alternative pathways 
allowing for membrane integration and proteolytic processing are possible based on existing 
data. The physical separation of the large cytoplasmic PLP2 protease domain and the luminal 
C-termini by the membrane interface would require that polyprotein processing of the 
nsp2
↓
nsp3 junction to be cleaved either in trans following membrane insertion, or that 
cleavage of nsp2-3 precedes membrane insertion. Similarly, previous data both shows that 
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the PLP2 possess both cis- and trans- cleavage activities (18) and that nsp2 has been 
additionally shown to interact with cellular chaperones known to participate in post-
translational membrane integration (28). Most simply, any nsp2 isoform resulting from a 
cleavage event between the PLP2 protease domain and the TM region would allow for 
physical separation of these domains and thus differential localization. While this would 
allow for unbound nsp2 isoforms to migrate to the nsp2-3 junction and process this site in 
trans, detailed studies defining the genesis of these cleavage isoforms are needed. 
Additionally, an N-terminal ER targeting sequence has not been identified, making it 
unlikely these unbound isoforms (most between 50-120 kDa; Fig. 4.3) would be able to 
traverse the to the luminal side of the ER to access the nsp2-3 junction at early time points 
during infection (prior to DMV/RVN formation). At later time points after DMV formation, 
nsp2 localizes diffusely within the perinuclear region (16, 50) and thus it is possible that 
trans-cleavage specificity could play some role at this stage.  
Alternatively, post-translational insertion into the ER membrane has been shown to 
occur via multiple pathways including signal recognition particle (SRP)-dependent (51), 
heat-shock protein (HSP70)-dependent (52), and ‘unassisted’ (53, 54) mechanisms. As a 
nascent apolar peptide emerges from the ribosomal tunnel, it requires immediate shielding 
from the aqueous cytosolic environment to protect against inappropriate folding or 
aggregation, either through direct membrane insertion (co-translational insertion) (55) or 
chaperone mediated nascent protein shielding (post-translational integration pathways) (52, 
56). The PRRSV nsp2 has been found to interact with multiple cellular proteins associated 
with translational regulation and membrane insertion, particularly the chaperone protein 
human leukocyte antigen (HLA)-B–associated transcript 3 (Bat3/Bag6/Scythe) (28). Bat3 is 
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a multi-functional chaperone protein that plays a central role in regulation of post-
translational ER membrane targeting (56-58), ubiquitin-dependent ER-associated protein 
degradation (ERAD) proteome targeting (59), and removal and degradation of mislocalized 
proteins (60). Bat3 functions by binding to nascent hydrophobic polypeptides as they emerge 
from the ribosomal tunnel, specifically binding long stretches of hydrophobic residues (57, 
61), maintaining hydrophobic proteins in a soluble state until membrane insertion (56). In 
addition, nsp2 has been found to also interact with other ER chaperone proteins implicated in 
post-translational membrane integration, HSP70 (28, 52) and binding immunoglobulin 
protein (Bip/GRP78/HSPA5) (32, 62). Bat3 appears to play a fundamental role in association 
with both of these proteins whereas Bat3 promotes the stability of HSP70 and Bip (63, 64). 
Bat3 and related holdase machinery (TRC35/UBL4) are present within reticulocyte lysates 
(57).  
Whether a transmembrane protein is processed co-translationally or post-
translationally, and which mechanism/pathway is utilized, most often relies on attributes of 
protein coding sequence adjacent to or within the hydrophobic area (43, 51, 65-69), however, 
the ‘rules’ dictating how protein sequence imparts these regulatory signals is currently not 
well understood (70). It is important to mention that all chaperone proteins that interact with 
nsp2 also participate in a diverse set of functions, and that interaction with nsp2 does not 
necessitate it is exclusively for post-translational roles associated with membrane integration. 
However, a core function of Bat3 is to bind hydrophobic regions of proteins in order to 
maintain solubility while a triage (protein quality control) decision is made regarding ER 
targeting or ubiquitin-dependent destruction (61). While it is postulated that Bat3 would 
function to directly target nsp2 for membrane insertion, the PLP2 protease possesses 
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deubiquitinating functionality (19, 20) that, if targeted for destruction, may rescue nsp2 from 
ULB4 ubiquitin-dependent degradation and further potentiate ER targeting.  
In this report we demonstrate nsp2 is an integral membrane protein and possesses an 
cytoplasmic/luminal topological orientation within the context of the cell-free in vitro 
translation assay. Research has shown that retention of proteins in membranes does not exist 
as a static state and the environment of the polar/apolar surface is dynamic and is managed 
by a range of physical forces and biological intermediaries (40, 49, 69-71). Future research is 
needed to define the membrane integration steps of nsp2, whether co-translationally or post-
translationally, and what the cellular and viral interacting partners may be. Stepping up 
studies into cellular in vitro and ex vivo systems using vectored nsp2, ORF1a, or competent 
infection studies should show if interaction with additional cellular or viral components 
induce altered integration or varied topologies. As noted earlier, nsp2 encodes two weak 
hydrophobic elements of unknown functionality (Fig. 4.8B). Initial attempts to map the 
transmembrane coding helices through mutational analysis failed to conclusively define 
which elements associate or embed within the membrane and require further investigation 
(data not shown). Studies showed a strong association of the full-length nsp2 and two large 
nsp2 isoforms with membranes (Fig. 4.5); and further demonstrated the C-termini of nsp2 is 
translocated through to the lumen surface of canine pancreatic membranes (Fig. 4.7-8). These 
results define nsp2 as an integral membrane protein of PRRSV. The demonstrated membrane 
integration of nsp2 within this report supports previous predicted functions of nsp2 
associated with membrane rearrangement and association with the PRRSV virion. 
Identification of a small class of membrane associated nsp2 isoforms of unknown function 
further highlight the complex composition of nsp2.  
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MATERIALS AND METHODS 
Construction of expression plasmids. pVR-2332 (DQ217415) template was amplified 
(Platinum Taq, Invitrogen) using custom DNA primers VR-nsp2-F: 5’-GCT GGA AAG AGA 
GCA AGA AAA GCA CG-3’ and VR-nsp2-R: 5’-TCC CCC TGA AGG CTT GGA AAT TTG 
C-3’ targeting the complete nsp2 coding region (VR-2332 1339nt-4926nt). Amplified 
products were gel purified using the QIAquick gel extraction kit [Qiagen] and underwent a 
second round of amplification (Phusion® High-Fidelity DNA polymerase, NEB) and gel 
purification. Purified PCR products were incubated with 12mM dATP [New England Biolabs 
(NEB)], GoTaq Flexi DNA polymerase (1.25U), and GoTaq reaction buffer (1X; 1.5mM 
MgCl2) [Promega] at 72°C for 20 minutes to introduce 3’ A-tail overhangs. A-tailed products 
were purified to remove reaction components [Zymogen Clean and Concentrator-5] and A-T 
cloned into the pGEM®-T EASY vector system per manufacturer’s instructions (Promega). 
Resulting ligations were transformed into either JM-109 (Promega) or Mach1 (Invitrogen) 
chemically competent cells per manufacturer’s instructions. Positive ligation clones grown 
under ampicillin resistance (100ug/ml; Sigma) were amplified and screened by restriction 
digest and sequenced for positive forward insertion. Correct clones were sequenced to cover 
the entire nsp2 coding region and flanking vector sequence. Two point mutations that altered 
the amino acid coding sequence were identified and restored to parental sequence with the 
QuikChange II XL site-directed mutagenesis kit (Agilent) and custom DNA mutagenesis 
primers. Additional restriction digestion and site-directed mutagenesis was completed 
directly upstream of the nsp2 5’ coding sequence to remove inefficient upstream start codons 
and an upstream NotI restriction site, and to introduce a novel PacI restriction site and a  
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Table 4.2. Sequence of oligonucleotides for insertion of exogenous FLAG epitope 
 
 
strong Kozak sequence flanked by the start codon (5’-GCCGCCGCCAUG-3’). The pcDNA 
3.0 cloning vector was also altered by site-directed mutagenesis to introduce a novel PacI 
restriction site directly upstream of the NotI restriction site (to facilitate directional cloning) 
by changing the sequence 5’-CATCACAC-3’ (vector sequence 954-961nt) to TTAAT↓TAA. 
pGEM-Nsp2 clones were digested with PacI and NotI restriction enzymes and the nsp2 insert 
was selected and gel purified [QIAquick gel extraction kit, Qiagen]. Purified inserts were 
directionally cloned into the pcDNA 3.0 expression vector downstream of the T7 
transcription initiation factor using the PacI/NotI restriction sites and the Blunt/TA ligase 
master mix [NEB]. The resulting expression construct was denoted as pNsp2 (1-1196aa). 
 To facilitate immunoprecipitation assays, expression constructs were engineered to 
encode an exogenous FLAG epitope (DYKDDDDK) either at the 5’ termini (pNsp2 N-
FLAG) or directly downstream of the nsp2 coding region (pNsp2 C-FLAG). Intermediate 
pNsp2 clones were engineered to possess a SbfI restriction site (CCTGCA
↓
GG) by site-
directed mutagenesis (pNsp2 5’SbfI: [AUG (CCTGCA↓GG) GCT GGA AAG… -3’]; pNsp2 
3’SbfI: [5’- …TCA GGG GGA (CCTGCA↓GG)…- 3’], bold = nsp2 sequence) flanking the 
5’ or 3’ termini of nsp2 (Table 4.2). A pair of synthetic oligonucleotides encoding the FLAG 
epitope (FLAG Forward and FLAG Reverse) was designed to encode flanking SbfI 
Name Primer Sequence
5'FLAG SDM Forward  '5- TTAATTAAGCCGCCGCCATG(CCTGCA↓GG)GCTGGAAAGAGAGCAAGAAA  -3'
5'FLAG SDM Reverse  '5- TTTCTTGCTCTCTTTCCAGC(CC↑TGCAGG)CATGGCGGCGGCTTAATTAA  -3'
3'FLAG SDM Forward  '5- TTTCCAAGCCTTCAGGGGGA(CCTGCA↓GG)ATCACTAGTGAATTCGCGGC  -3'
3'FLAG SDM Reverse  '5- GCCGCGAATTCACTAGTGAT(CC↑TGCAGG)TCCCCCTGAAGGCTTGGAAA  -3'
FLAG Forward  '5- ATTATT(CCTGCA↓GG)CGACTACAAAGACGATGACGACAAGA(CCTGCA↓GG)CGCAGCA  -3'
FLAG Reverse  '5- TGCTGCG(CC↑TGCAGG)TCTTGTCGTCATCGTCTTTGTAGTCG(CC↑TGCAGG)AATAAT  -3'
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restriction sites (Table 4.2). The FLAG oligonucleotides were annealed by first heating to 
95°C and then reducing the temperature 1°C/min in a thermocycler [Eppendorf] until 20°C is 
reached. The annealed FLAG oligonucleotides were digested by SbfI and ligated into pNsp2 
5’SbfI or pNsp2 3’SbfI at a 1:1 molar ratio to generate in-frame FLAG-tagged expression 
constructs pNsp2 N-FLAG and pNsp2 C-FLAG, respectively.  
Bioinformatic predictions. pVR-2332 (DQ217415) nsp2 protein coding sequence was 
analyzed by the transmembrane prediction algorithms Phobius [‘Normal prediction’ method; 
(33)]; HMMTOP 2.0 (34); SCAMPI (35); TOPCONS (36); OCTOPUS (37); PRO/PRODIV-
TMHMM (38); and MemBrain [TMH prediction; (39)] using default settings unless 
otherwise noted.  
Cell-free translation of nsp2. Nsp2 expression constructs were translated using the TNT® 
T7 coupled transcription/translation reticulocyte lysate system (Promega) with some 
modifications to the manufacturer’s instructions. The rabbit reticulocyte lysate was thawed 
quickly at 37°C prior to being placed on ice, all other components including H20 and DNA 
template were chilled to 4°C before assembling translation reactions. Reactions were 
assembled on ice using 1ug DNA template per 25μl translation reaction either with or 
without the addition of canine pancreatic microsomal membranes (microsomes; Promega; see 
below). RNasin® Plus RNase inhibitor (Promega) was added to each reaction (1.6U/μl per 
rxn) to inhibit RNA degradation during the translation reaction. It was found to be important 
to increase the amino acid mixture [minus cysteine] (Promega) 3-fold to a 0.06mM final 
concentration to enable efficient translation of the large 129kDa nsp2 protein. All other 
reaction components were added per manufacturer’s specifications. [35]-S cysteine (Cysteine 
L-[35]; 10μCi/μl; PerkinElmer) thawed on ice was added to the translation reaction after all 
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other components (0.4mCi/mL final concentration). When used, microsomes were added to 
the translation reaction as a final step at a dilution of 1μl microsomes per 25μl translation 
reaction volume. The reaction was then mixed gently followed by incubation at 25°C for 1 
hour. Lowering the incubation temperature to 25°C was found to aid expression of full-
length nsp2 product. All reactions were then quickly chilled to 4°C. Translation products 
were quantified by measuring the amount of incorporated product (scintillation counts; 
Promega #TB126) prior to use in downstream assays.  
Polyacrylamide gel electrophoresis. Reactions to be assessed by polyacrylamide gel 
electrophoresis (PAGE) were diluted to 15μl in phosphate-buffered saline (PBS; 10mM 
Na2HPO4/KH2PO4, 137mM NaCl, pH 7.4) as needed. Samples were reduced with 4X 
NuPAGE® LDS sample buffer (Life Technologies) supplemented with 10% v/v DTT 
(500mM; Life Technologies) and 30% w/v urea (Mallinckrodt). Reducing buffer was added 
to a 1X final concentration followed by heat denaturation at 100°C for 5 minutes. Reduced 
and denatured samples were loaded onto NuPAGE® Novex® 4-12% Bis-Tris 
polyacrylamide gels (Life Technologies) and electrophoresed at constant voltage in 1X 
Novex® 2-(N-morpholino)ethanesulfonic acid running buffer (MES; 145V) (Life 
Technologies) or 1X Novex® 3-(N-morpholino) propanesulfonic acid running buffer 
(MOPS; 125V) (Life Technologies) supplemented with NuPAGE® antioxidant (Life 
Technologies) per manufacturer’s instructions. PAGE separated gels were incubated in gel 
drying buffer [50% methanol (HPLC grade; Honeywell), 7.5% glacial acetic acid (Fisher 
Chemical), and 10% glycerol (ACS grade; Macron)] for 30 minutes at room temperature 
(RT), further dehydrated in 200 proof ethanol (ETOH, Decon Laboratories) for 15 minutes at 
RT (72), and then submerged in Amersham™ Amplify™ fluorographic reagent (GE 
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Healthcare) for 30min at RT to infuse the gel with the fluorographic reagent. PAGE products 
were dried completely under vacuum at 80°C for 2 hours. PAGE separated [35]-S-cysteine 
labeled products were imaged using BIOMAX MR High-Resolution Film (Carestream). 
Immunoprecipitation. Immunoprecipitation (IP) pull-down assays were completed with the 
use of the magnetic DYKDDDDK (FLAG) immunoprecipitation kit (ClonTech) per 
manufacturer’s instructions, with one exception. Anti-DYKDDDDK magnetic beads were 
pre-absorbed by suspending 20μl beads into 1ml ClonTech IP lysis buffer supplemented with 
0.1% BSA and allowed to tumble at 4°C overnight prior to the addition of translation 
products. Approximately 100,000 counts per translation product were then added to the pre-
absorbed anti-DYKDDDDK beads suspended in 0.1%BSA/ IP lysis buffer and tumbled for 
an additional night at 4°C. Beads were then washed 3 times with ClonTech IP wash buffer 
per manufacturer’s instructions. Washed IP reactions were eluted with the ClonTech IP 
elution buffer at RT for 5 minutes. IP beads were removed from eluted products prior to 
analysis by PAGE under reducing and denaturing conditions.  
Isolation of the microsomal fraction. Approximately 250,000 counts per translation 
reaction were diluted with chilled (4°C) PBS or tris-buffered sucrose (TS buffer; 25mM Tris-
HCl pH7.5, 250mM sucrose) (27). Reactions were diluted to a final volume of 10 mL and 
mixed thoroughly by gently pipetting. Diluted translation products were stabilized at 4°C for 
≥1 hour, followed by pelleting at 150,000xg, 4°C, for 1 hour. Supernatants from high-speed 
pelleting were discarded and the resulting pellets were eluted in low volumes (15-25ul) of 
chilled PBS or TS buffer while keeping all components on ice.  
Protease protection assay. Expression constructs and controls were translated as described 
above, either with or without the addition of canine pancreatic microsomal membranes. 
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Translated products were processed to isolate the microsomal fraction (as described above) 
using TS buffer. Pelleted products were eluted in TS buffer and were stabilized at 4°C for ≥1 
hour. Stabilized products (4°C) were then treated with proteinase K (Ambion) (0.6mg/ml) for 
2 hours followed by proteinase K inactivation with fresh phenylmethylsulfonyl fluoride 
(PMSF) (10mM final concentration) and incubated at 4°C overnight. Protease protection 
assay (PPA) reactions were assessed by IP and PAGE analysis as described above.  
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CHAPTER 5. GENERAL CONCLUSIONS 
 
 The focus of this thesis was centered on investigations into the molecular biology of 
PRRSV nsp2. The unique attributes of nsp2 including its large size, genetic heterogeneity, 
immunosuppressive functionality, and essential activities supporting viral replication made 
the nsp2 an intriguing target to study. At the core of the original hypothesis was the intent to 
identify a possible mechanism that could potentiate the high rate of mutation within the nsp2 
hypervariable domain (HV). A set of custom antibodies targeting conserved regions of the 
four domains of nsp2 [PLP2 protease (OTU), HV, transmembrane (TM) domain, and the C-
termini] were utilized with a highly stringent virus purification strategy to define the 
packaging of nsp2 and an abundant population of subdominant nsp2 isoforms. Comparison 
of western blot analysis of infected cell lysates versus highly purified virions showed the 
enrichment of many lower molecular weight nsp2 isoforms within the purified virion. Both 
α-OTU and α-HV antibodies positively and selectively detected nsp2 on purified virions by 
immunoelectron microscopy (IEM); however, the TM and C-terminal domains were unable 
to be efficiently detected by IEM. These data suggested nsp2 maintained an N-terminal 
ectodomain on the virion surface and possibly associated with the viral envelope through the 
putative TM region. Immunofluorescence assay (IFA) detected the OTU, HV and C-terminal 
domains within infected cells, but the TM domain could not be labeled, further suggesting 
the TM domain was functional and that the target epitope was unavailable for detection by 
antibody labeling. Interestingly, IFA also showed differential localization patterns of nsp2 
depended on which epitope was targeted. The N-terminal OTU domain displayed a diffuse 
cytoplasmic and perinuclear localization pattern whereas the C-terminal domain appeared 
126 
 
highly restricted to the perinuclear region. It is postulated that nsp2 isoforms lacking the TM 
domain are able to differentially localize throughout the cytoplasmic space to regulate non-
membrane associated host processes such as the defined PLP2 OTU downregulation of RIG-I 
signaling (1).  
 We next sought to characterize the TM domain of nsp2 because, while the membrane 
association of nsp2 appears critical for the activities of nsp2 both intracellularly and for 
packaging, the functionality of the TM domain or the resulting topology had never been 
assessed. Nsp2 was found to strongly associate with the membrane fraction. Surprisingly, in 
addition to the full-length nsp2, two lower molecular weight isoforms (117 and 106 kDa) 
were enriched within the membrane fraction. Enrichment of these subdominant isoforms 
suggests a stronger association with the membrane. While the composition of these enriched 
isoforms are unknown, curiously, the recently described translational isoform (nsp2-TF) 
resulting from a -2 ribosomal frame shift within the putative TM1 helix yields a much 
stronger hydrophobic domain. Further analysis of the membrane associated fraction by 
protease protection assay (proteinase K) and immunoprecipitation (α-FLAG) conclusively 
defined nsp2 as an integral membrane protein and additionally demonstrated that nsp2 
integrated in an unexpected topological orientation within the in vitro cell-free translation 
system. Nsp2 integrates within the microsomal membranes with the N- and C-terminus on 
opposite sides of the membrane whereas the C-termini was transported across the membrane 
surface into the luminal side of the microsomes. This out/in topology of nsp2 has important 
implications on the polyprotein processing cascade, specifically the mechanism of cleavage 
of the nsp2
↓
nsp3 junction (cis versus trans) as well as the topological orientation of 
downstream replicase proteins.  
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